Disease specific cell death gene regulator search
Search Results:
Huntington's Disease (HD) specific apoptosis gene regulaors.
Different color in column1 means high , low , non-diff expressed gene in disease.
| NO. | Disease | CellDeathType | Genesymbol | Fullname | Control_mean | Disease_mean | log2FC | pvalue | padj | Weight | Detail |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Huntington's Disease (HD) | apoptosis | ENDOD1 | endonuclease domain containing 1 | 0.53 | -0.24 | -1.15 | 0.0 | 0.79 | 100.0 | Detail |
| 2 | Huntington's Disease (HD) | apoptosis | PAWR | pro-apoptotic WT1 regulator | -0.33 | 0.12 | -1.45 | 0.0 | 0.79 | 91.12 | Detail |
| 3 | Huntington's Disease (HD) | apoptosis | XBP1 | X-box binding protein 1 | 0.44 | -0.27 | -0.69 | 0.01 | 0.79 | 90.13 | Detail |
| 4 | Huntington's Disease (HD) | apoptosis | TFAP2A | transcription factor AP-2 alpha | 0.26 | -0.1 | -1.45 | 0.01 | 0.79 | 89.14 | Detail |
| 5 | Huntington's Disease (HD) | apoptosis | BCL2L1 | BCL2 like 1 | 0.51 | -0.2 | -1.36 | 0.01 | 0.79 | 88.82 | Detail |
| 6 | Huntington's Disease (HD) | apoptosis | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 0.32 | -0.26 | -0.31 | 0.01 | 0.79 | 88.49 | Detail |
| 7 | Huntington's Disease (HD) | apoptosis | NRP1 | neuropilin 1 | -0.45 | 0.25 | -0.88 | 0.01 | 0.79 | 85.86 | Detail |
| 8 | Huntington's Disease (HD) | apoptosis | STRADB | STE20 related adaptor beta | 0.49 | -0.21 | -1.2 | 0.01 | 0.79 | 83.55 | Detail |
| 9 | Huntington's Disease (HD) | apoptosis | ELL3 | elongation factor for RNA polymerase II 3 | -0.36 | 0.25 | -0.53 | 0.01 | 0.79 | 83.22 | Detail |
| 10 | Huntington's Disease (HD) | apoptosis | CREB3 | cAMP responsive element binding protein 3 | -0.25 | 0.18 | -0.47 | 0.01 | 0.79 | 82.89 | Detail |
| 11 | Huntington's Disease (HD) | apoptosis | TNF | tumor necrosis factor | 0.37 | -0.28 | -0.39 | 0.01 | 0.79 | 80.76 | Detail |
| 12 | Huntington's Disease (HD) | apoptosis | RNASE3 | ribonuclease A family member 3 | 0.27 | -0.27 | 0.01 | 0.01 | 0.79 | 79.93 | Detail |
| 13 | Huntington's Disease (HD) | apoptosis | CASP8AP2 | caspase 8 associated protein 2 | -0.41 | 0.17 | -1.29 | 0.01 | 0.79 | 79.28 | Detail |
| 14 | Huntington's Disease (HD) | apoptosis | PRKRA | protein activator of interferon induced protein kinase EIF2AK2 | -0.33 | 0.22 | -0.56 | 0.02 | 0.79 | 78.62 | Detail |
| 15 | Huntington's Disease (HD) | apoptosis | YBX3 | Y-box binding protein 3 | 0.42 | -0.23 | -0.83 | 0.02 | 0.79 | 78.62 | Detail |
| 16 | Huntington's Disease (HD) | apoptosis | PARL | presenilin associated rhomboid like | -0.45 | 0.13 | -1.82 | 0.02 | 0.79 | 77.96 | Detail |
| 17 | Huntington's Disease (HD) | apoptosis | SERPINE1 | serpin family E member 1 | 0.37 | -0.18 | -1.07 | 0.02 | 0.79 | 77.3 | Detail |
| 18 | Huntington's Disease (HD) | apoptosis | ATP2A1 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 | 0.33 | -0.27 | -0.27 | 0.02 | 0.79 | 76.64 | Detail |
| 19 | Huntington's Disease (HD) | apoptosis | ITPR1 | inositol 1,4,5-trisphosphate receptor type 1 | -0.39 | 0.2 | -0.99 | 0.02 | 0.79 | 76.32 | Detail |
| 20 | Huntington's Disease (HD) | apoptosis | CASP4 | caspase 4 | -0.32 | 0.19 | -0.73 | 0.02 | 0.79 | 75.99 | Detail |
| 21 | Huntington's Disease (HD) | apoptosis | PSMB1 | proteasome 20S subunit beta 1 | -0.37 | 0.14 | -1.38 | 0.02 | 0.79 | 75.33 | Detail |
| 22 | Huntington's Disease (HD) | apoptosis | PINK1 | PTEN induced kinase 1 | 0.53 | -0.2 | -1.42 | 0.02 | 0.79 | 75.0 | Detail |
| 23 | Huntington's Disease (HD) | apoptosis | GCLM | glutamate-cysteine ligase modifier subunit | 0.29 | -0.15 | -0.95 | 0.02 | 0.82 | 73.68 | Detail |
| 24 | Huntington's Disease (HD) | apoptosis | ID3 | inhibitor of DNA binding 3 | -0.35 | 0.1 | -1.87 | 0.02 | 0.82 | 73.36 | Detail |
| 25 | Huntington's Disease (HD) | apoptosis | PF4 | platelet factor 4 | 0.32 | -0.29 | -0.13 | 0.03 | 0.87 | 71.38 | Detail |
| 26 | Huntington's Disease (HD) | apoptosis | G0S2 | G0/G1 switch 2 | -0.29 | 0.16 | -0.9 | 0.03 | 0.87 | 71.05 | Detail |
| 27 | Huntington's Disease (HD) | apoptosis | MAPK14 | mitogen-activated protein kinase 14 | -0.25 | 0.15 | -0.72 | 0.03 | 0.87 | 70.39 | Detail |
| 28 | Huntington's Disease (HD) | apoptosis | NONO | non-POU domain containing octamer binding | -0.55 | 0.14 | -2.02 | 0.03 | 0.87 | 69.41 | Detail |
| 29 | Huntington's Disease (HD) | apoptosis | MAEL | maelstrom spermatogenic transposon silencer | 0.36 | -0.15 | -1.26 | 0.04 | 0.87 | 68.09 | Detail |
| 30 | Huntington's Disease (HD) | apoptosis | BAG6 | BAG cochaperone 6 | 0.46 | -0.15 | -1.59 | 0.04 | 0.87 | 67.76 | Detail |
| 31 | Huntington's Disease (HD) | apoptosis | PRKAR2B | protein kinase cAMP-dependent type II regulatory subunit beta | 0.28 | -0.23 | -0.29 | 0.04 | 0.87 | 67.43 | Detail |
| 32 | Huntington's Disease (HD) | apoptosis | HERPUD1 | homocysteine inducible ER protein with ubiquitin like domain 1 | -0.38 | 0.14 | -1.5 | 0.04 | 0.87 | 67.11 | Detail |
| 33 | Huntington's Disease (HD) | apoptosis | GATA1 | GATA binding protein 1 | 0.39 | -0.15 | -1.37 | 0.04 | 0.87 | 66.78 | Detail |
| 34 | Huntington's Disease (HD) | apoptosis | MYLPF | myosin light chain 11 | 0.26 | -0.1 | -1.38 | 0.04 | 0.87 | 65.13 | Detail |
| 35 | Huntington's Disease (HD) | apoptosis | PSMB3 | proteasome 20S subunit beta 3 | -0.32 | 0.13 | -1.33 | 0.04 | 0.87 | 65.13 | Detail |
| 36 | Huntington's Disease (HD) | apoptosis | BMPR2 | bone morphogenetic protein receptor type 2 | -0.26 | 0.1 | -1.34 | 0.05 | 0.87 | 64.8 | Detail |
| 37 | Huntington's Disease (HD) | apoptosis | E2F4 | E2F transcription factor 4 | 0.44 | -0.11 | -2.04 | 0.05 | 0.87 | 64.8 | Detail |
| 38 | Huntington's Disease (HD) | apoptosis | PPP2CB | protein phosphatase 2 catalytic subunit beta | 0.36 | -0.17 | -1.11 | 0.05 | 0.87 | 64.47 | Detail |
| 39 | Huntington's Disease (HD) | apoptosis | GCLC | glutamate-cysteine ligase catalytic subunit | 0.21 | -0.19 | -0.18 | 0.05 | 0.87 | 64.14 | Detail |
| 40 | Huntington's Disease (HD) | apoptosis | GSK3A | glycogen synthase kinase 3 alpha | 0.38 | -0.14 | -1.41 | 0.05 | 0.87 | 64.14 | Detail |
| 41 | Huntington's Disease (HD) | apoptosis | BRCA1 | BRCA1 DNA repair associated | -0.36 | 0.08 | -2.17 | 0.05 | 0.87 | 63.16 | Detail |
| 42 | Huntington's Disease (HD) | apoptosis | CLU | clusterin | 0.29 | -0.21 | -0.49 | 0.05 | 0.87 | 63.16 | Detail |
| 43 | Huntington's Disease (HD) | apoptosis | CTTN | cortactin | 0.27 | -0.19 | -0.53 | 0.05 | 0.87 | 63.16 | Detail |
| 44 | Huntington's Disease (HD) | apoptosis | ARHGDIB | Rho GDP dissociation inhibitor beta | 0.3 | -0.05 | -2.57 | 0.05 | 0.87 | 62.83 | Detail |
| 45 | Huntington's Disease (HD) | apoptosis | PCGF2 | polycomb group ring finger 2 | 0.36 | -0.08 | -2.25 | 0.06 | 0.87 | 62.17 | Detail |
| 46 | Huntington's Disease (HD) | apoptosis | BNIP3L | BCL2 interacting protein 3 like | 0.35 | -0.17 | -1.04 | 0.06 | 0.87 | 62.17 | Detail |
| 47 | Huntington's Disease (HD) | apoptosis | CUL4A | cullin 4A | 0.3 | -0.15 | -1.04 | 0.06 | 0.87 | 62.17 | Detail |
| 48 | Huntington's Disease (HD) | apoptosis | FIS1 | fission, mitochondrial 1 | 0.38 | -0.12 | -1.64 | 0.06 | 0.87 | 62.17 | Detail |
| 49 | Huntington's Disease (HD) | apoptosis | MAP2K5 | mitogen-activated protein kinase kinase 5 | -0.22 | 0.13 | -0.81 | 0.06 | 0.87 | 61.51 | Detail |
| 50 | Huntington's Disease (HD) | apoptosis | RBX1 | ring-box 1 | 0.37 | -0.05 | -2.82 | 0.06 | 0.87 | 61.18 | Detail |
| 51 | Huntington's Disease (HD) | apoptosis | IL4 | interleukin 4 | 0.03 | -0.17 | 2.34 | 0.06 | 0.87 | 61.18 | Detail |
| 52 | Huntington's Disease (HD) | apoptosis | ROCK2 | Rho associated coiled-coil containing protein kinase 2 | -0.44 | 0.03 | -4.11 | 0.06 | 0.87 | 60.86 | Detail |
| 53 | Huntington's Disease (HD) | apoptosis | IFI6 | interferon alpha inducible protein 6 | -0.19 | 0.13 | -0.56 | 0.06 | 0.87 | 60.86 | Detail |
| 54 | Huntington's Disease (HD) | apoptosis | HIPK1 | homeodomain interacting protein kinase 1 | 0.41 | -0.2 | -1.04 | 0.06 | 0.87 | 60.53 | Detail |
| 55 | Huntington's Disease (HD) | apoptosis | SH3RF1 | SH3 domain containing ring finger 1 | 0.27 | -0.19 | -0.47 | 0.06 | 0.87 | 60.53 | Detail |
| 56 | Huntington's Disease (HD) | apoptosis | CEACAM6 | CEA cell adhesion molecule 6 | 0.25 | -0.28 | 0.19 | 0.06 | 0.87 | 60.2 | Detail |
| 57 | Huntington's Disease (HD) | apoptosis | BRCA2 | BRCA2 DNA repair associated | -0.21 | 0.16 | -0.38 | 0.06 | 0.87 | 59.87 | Detail |
| 58 | Huntington's Disease (HD) | apoptosis | E2F2 | E2F transcription factor 2 | 0.44 | -0.13 | -1.71 | 0.07 | 0.87 | 59.54 | Detail |
| 59 | Huntington's Disease (HD) | apoptosis | RNF41 | ring finger protein 41 | -0.33 | 0.06 | -2.5 | 0.07 | 0.87 | 59.54 | Detail |
| 60 | Huntington's Disease (HD) | apoptosis | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | -0.28 | 0.12 | -1.17 | 0.07 | 0.87 | 58.88 | Detail |
| 61 | Huntington's Disease (HD) | apoptosis | FOXO3 | forkhead box O3 | 0.44 | -0.14 | -1.65 | 0.07 | 0.87 | 58.88 | Detail |
| 62 | Huntington's Disease (HD) | apoptosis | TYROBP | transmembrane immune signaling adaptor TYROBP | -0.28 | 0.06 | -2.14 | 0.07 | 0.87 | 58.88 | Detail |
| 63 | Huntington's Disease (HD) | apoptosis | IFI27 | interferon alpha inducible protein 27 | 0.27 | -0.11 | -1.23 | 0.07 | 0.87 | 58.55 | Detail |
| 64 | Huntington's Disease (HD) | apoptosis | LTBP1 | latent transforming growth factor beta binding protein 1 | 0.29 | -0.22 | -0.38 | 0.07 | 0.87 | 58.22 | Detail |
| 65 | Huntington's Disease (HD) | apoptosis | PSMF1 | proteasome inhibitor subunit 1 | 0.46 | -0.13 | -1.85 | 0.07 | 0.87 | 58.22 | Detail |
| 66 | Huntington's Disease (HD) | apoptosis | PSME1 | proteasome activator subunit 1 | -0.17 | 0.15 | -0.14 | 0.07 | 0.87 | 57.89 | Detail |
| 67 | Huntington's Disease (HD) | apoptosis | BCL2A1 | BCL2 related protein A1 | -0.32 | 0.15 | -1.07 | 0.07 | 0.87 | 57.89 | Detail |
| 68 | Huntington's Disease (HD) | apoptosis | COL2A1 | collagen type II alpha 1 chain | 0.31 | -0.07 | -2.17 | 0.07 | 0.87 | 57.89 | Detail |
| 69 | Huntington's Disease (HD) | apoptosis | STOML2 | stomatin like 2 | 0.32 | -0.1 | -1.71 | 0.08 | 0.87 | 57.57 | Detail |
| 70 | Huntington's Disease (HD) | apoptosis | USP25 | ubiquitin specific peptidase 25 | -0.33 | 0.09 | -1.93 | 0.08 | 0.87 | 57.57 | Detail |
| 71 | Huntington's Disease (HD) | apoptosis | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | -0.27 | 0.07 | -1.97 | 0.08 | 0.87 | 57.24 | Detail |
| 72 | Huntington's Disease (HD) | apoptosis | PLAGL2 | PLAG1 like zinc finger 2 | 0.2 | -0.21 | 0.05 | 0.08 | 0.87 | 57.24 | Detail |
| 73 | Huntington's Disease (HD) | apoptosis | ZNF622 | zinc finger protein 622 | -0.09 | 0.13 | 0.66 | 0.08 | 0.87 | 56.58 | Detail |
| 74 | Huntington's Disease (HD) | apoptosis | PSMD2 | proteasome 26S subunit ubiquitin receptor, non-ATPase 2 | 0.33 | -0.15 | -1.17 | 0.08 | 0.87 | 56.25 | Detail |
| 75 | Huntington's Disease (HD) | apoptosis | CD14 | CD14 molecule | -0.24 | 0.11 | -1.17 | 0.08 | 0.87 | 56.25 | Detail |
| 76 | Huntington's Disease (HD) | apoptosis | FLCN | folliculin | 0.37 | -0.07 | -2.3 | 0.08 | 0.87 | 55.92 | Detail |
| 77 | Huntington's Disease (HD) | apoptosis | CD44 | CD44 molecule (IN blood group) | -0.34 | 0.12 | -1.49 | 0.09 | 0.87 | 55.59 | Detail |
| 78 | Huntington's Disease (HD) | apoptosis | GABARAP | GABA type A receptor-associated protein | 0.33 | -0.06 | -2.49 | 0.09 | 0.87 | 55.59 | Detail |
| 79 | Huntington's Disease (HD) | apoptosis | NKX3-1 | NK3 homeobox 1 | 0.33 | -0.09 | -1.87 | 0.09 | 0.87 | 55.59 | Detail |
| 80 | Huntington's Disease (HD) | apoptosis | TGFB2 | transforming growth factor beta 2 | 0.25 | -0.1 | -1.26 | 0.09 | 0.87 | 54.93 | Detail |
| 81 | Huntington's Disease (HD) | apoptosis | CSDE1 | cold shock domain containing E1 | 0.2 | -0.12 | -0.8 | 0.09 | 0.87 | 54.93 | Detail |
| 82 | Huntington's Disease (HD) | apoptosis | PLA2G12A | phospholipase A2 group XIIA | 0.3 | -0.06 | -2.26 | 0.09 | 0.87 | 54.93 | Detail |
| 83 | Huntington's Disease (HD) | apoptosis | ERCC6 | ERCC excision repair 6, chromatin remodeling factor | -0.33 | 0.15 | -1.15 | 0.09 | 0.87 | 54.61 | Detail |
| 84 | Huntington's Disease (HD) | apoptosis | PDIA3 | protein disulfide isomerase family A member 3 | -0.26 | 0.09 | -1.53 | 0.09 | 0.87 | 54.28 | Detail |
| 85 | Huntington's Disease (HD) | apoptosis | IL3RA | interleukin 3 receptor subunit alpha | 0.16 | -0.22 | 0.51 | 0.1 | 0.87 | 53.95 | Detail |
| 86 | Huntington's Disease (HD) | apoptosis | MSX1 | msh homeobox 1 | 0.34 | -0.04 | -3.16 | 0.1 | 0.87 | 53.95 | Detail |
| 87 | Huntington's Disease (HD) | apoptosis | UBQLN1 | ubiquilin 1 | 0.16 | -0.09 | -0.9 | 0.1 | 0.87 | 53.62 | Detail |
| 88 | Huntington's Disease (HD) | apoptosis | NGF | nerve growth factor | -0.14 | 0.21 | 0.55 | 0.1 | 0.87 | 53.62 | Detail |
| 89 | Huntington's Disease (HD) | apoptosis | CD70 | CD70 molecule | 0.18 | -0.05 | -1.7 | 0.1 | 0.87 | 53.29 | Detail |
| 90 | Huntington's Disease (HD) | apoptosis | SP100 | SP100 nuclear antigen | -0.24 | 0.11 | -1.06 | 0.1 | 0.87 | 52.96 | Detail |
| 91 | Huntington's Disease (HD) | apoptosis | HELLS | helicase, lymphoid specific | -0.27 | 0.14 | -0.95 | 0.1 | 0.87 | 52.63 | Detail |
| 92 | Huntington's Disease (HD) | apoptosis | PPP3R1 | protein phosphatase 3 regulatory subunit B, alpha | 0.22 | -0.05 | -2.21 | 0.11 | 0.87 | 52.3 | Detail |
| 93 | Huntington's Disease (HD) | apoptosis | SOD2 | superoxide dismutase 2 | 0.34 | -0.14 | -1.32 | 0.11 | 0.87 | 52.3 | Detail |
| 94 | Huntington's Disease (HD) | apoptosis | DAB2IP | DAB2 interacting protein | 0.2 | -0.12 | -0.74 | 0.11 | 0.87 | 51.97 | Detail |
| 95 | Huntington's Disease (HD) | apoptosis | IFI16 | interferon gamma inducible protein 16 | -0.29 | 0.15 | -0.98 | 0.11 | 0.87 | 51.97 | Detail |
| 96 | Huntington's Disease (HD) | apoptosis | PDK2 | pyruvate dehydrogenase kinase 2 | 0.36 | -0.1 | -1.82 | 0.11 | 0.87 | 51.97 | Detail |
| 97 | Huntington's Disease (HD) | apoptosis | AVP | arginine vasopressin | 0.32 | -0.05 | -2.59 | 0.11 | 0.87 | 51.64 | Detail |
| 98 | Huntington's Disease (HD) | apoptosis | JUN | Jun proto-oncogene, AP-1 transcription factor subunit | -0.34 | 0.11 | -1.6 | 0.11 | 0.87 | 51.32 | Detail |
| 99 | Huntington's Disease (HD) | apoptosis | CREB3L1 | cAMP responsive element binding protein 3 like 1 | 0.39 | 0.01 | -5.02 | 0.12 | 0.87 | 50.99 | Detail |
| 100 | Huntington's Disease (HD) | apoptosis | BMF | Bcl2 modifying factor | 0.07 | -0.16 | 1.23 | 0.12 | 0.87 | 50.66 | Detail |
| 101 | Huntington's Disease (HD) | apoptosis | AGTR2 | angiotensin II receptor type 2 | 0.38 | -0.07 | -2.54 | 0.12 | 0.87 | 50.66 | Detail |
| 102 | Huntington's Disease (HD) | apoptosis | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.29 | -0.1 | -1.59 | 0.12 | 0.87 | 50.66 | Detail |
| 103 | Huntington's Disease (HD) | apoptosis | E2F5 | E2F transcription factor 5 | -0.23 | 0.05 | -2.12 | 0.12 | 0.87 | 50.66 | Detail |
| 104 | Huntington's Disease (HD) | apoptosis | IL19 | interleukin 19 | -0.04 | 0.22 | 2.41 | 0.12 | 0.87 | 50.66 | Detail |
| 105 | Huntington's Disease (HD) | apoptosis | SKIL | SKI like proto-oncogene | -0.32 | 0.04 | -2.94 | 0.12 | 0.87 | 50.66 | Detail |
| 106 | Huntington's Disease (HD) | apoptosis | IRAK4 | interleukin 1 receptor associated kinase 4 | -0.35 | 0.2 | -0.82 | 0.12 | 0.87 | 50.33 | Detail |
| 107 | Huntington's Disease (HD) | apoptosis | TREM2 | triggering receptor expressed on myeloid cells 2 | 0.33 | 0.01 | -5.7 | 0.12 | 0.87 | 50.33 | Detail |
| 108 | Huntington's Disease (HD) | apoptosis | THBS3 | thrombospondin 3 | 0.27 | -0.06 | -2.18 | 0.12 | 0.87 | 50.0 | Detail |
| 109 | Huntington's Disease (HD) | apoptosis | GHITM | growth hormone inducible transmembrane protein | 0.13 | -0.16 | 0.26 | 0.12 | 0.87 | 50.0 | Detail |
| 110 | Huntington's Disease (HD) | apoptosis | BMP6 | bone morphogenetic protein 6 | 0.21 | -0.16 | -0.35 | 0.13 | 0.87 | 49.67 | Detail |
| 111 | Huntington's Disease (HD) | apoptosis | CDKN1A | cyclin dependent kinase inhibitor 1A | 0.25 | -0.13 | -0.92 | 0.13 | 0.87 | 49.67 | Detail |
| 112 | Huntington's Disease (HD) | apoptosis | HGF | hepatocyte growth factor | -0.35 | -0.03 | -3.55 | 0.13 | 0.87 | 49.67 | Detail |
| 113 | Huntington's Disease (HD) | apoptosis | PTPMT1 | protein tyrosine phosphatase mitochondrial 1 | -0.22 | 0.18 | -0.31 | 0.13 | 0.87 | 49.67 | Detail |
| 114 | Huntington's Disease (HD) | apoptosis | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | -0.28 | 0.05 | -2.57 | 0.13 | 0.87 | 49.67 | Detail |
| 115 | Huntington's Disease (HD) | apoptosis | SREBF1 | sterol regulatory element binding transcription factor 1 | 0.27 | -0.11 | -1.31 | 0.13 | 0.87 | 49.34 | Detail |
| 116 | Huntington's Disease (HD) | apoptosis | GPX1 | glutathione peroxidase 1 | 0.39 | -0.12 | -1.73 | 0.13 | 0.87 | 49.34 | Detail |
| 117 | Huntington's Disease (HD) | apoptosis | UBB | ubiquitin B | 0.31 | -0.08 | -1.93 | 0.13 | 0.87 | 49.01 | Detail |
| 118 | Huntington's Disease (HD) | apoptosis | CRH | corticotropin releasing hormone | 0.15 | -0.15 | 0.05 | 0.13 | 0.87 | 49.01 | Detail |
| 119 | Huntington's Disease (HD) | apoptosis | AKT3 | AKT serine/threonine kinase 3 | -0.2 | 0.17 | -0.2 | 0.13 | 0.87 | 48.68 | Detail |
| 120 | Huntington's Disease (HD) | apoptosis | PRDX2 | peroxiredoxin 2 | 0.43 | -0.04 | -3.48 | 0.13 | 0.87 | 48.68 | Detail |
| 121 | Huntington's Disease (HD) | apoptosis | TMEM102 | transmembrane protein 102 | 0.17 | -0.08 | -1.17 | 0.14 | 0.87 | 48.36 | Detail |
| 122 | Huntington's Disease (HD) | apoptosis | ZFYVE16 | zinc finger FYVE-type containing 16 | -0.38 | 0.08 | -2.26 | 0.14 | 0.87 | 48.03 | Detail |
| 123 | Huntington's Disease (HD) | apoptosis | NF1 | neurofibromin 1 | 0.13 | -0.15 | 0.19 | 0.14 | 0.87 | 48.03 | Detail |
| 124 | Huntington's Disease (HD) | apoptosis | BCAP31 | B cell receptor associated protein 31 | 0.22 | -0.06 | -1.94 | 0.14 | 0.87 | 47.86 | Detail |
| 125 | Huntington's Disease (HD) | apoptosis | NOTCH1 | notch receptor 1 | 0.2 | -0.16 | -0.38 | 0.14 | 0.87 | 47.7 | Detail |
| 126 | Huntington's Disease (HD) | apoptosis | CRIP1 | cysteine rich protein 1 | 0.22 | -0.14 | -0.7 | 0.15 | 0.87 | 47.2 | Detail |
| 127 | Huntington's Disease (HD) | apoptosis | IL1A | interleukin 1 alpha | -0.23 | 0.13 | -0.81 | 0.15 | 0.87 | 47.04 | Detail |
| 128 | Huntington's Disease (HD) | apoptosis | INHBA | inhibin subunit beta A | 0.16 | -0.23 | 0.49 | 0.15 | 0.87 | 47.04 | Detail |
| 129 | Huntington's Disease (HD) | apoptosis | EPO | erythropoietin | 0.23 | -0.03 | -3.17 | 0.15 | 0.87 | 47.04 | Detail |
| 130 | Huntington's Disease (HD) | apoptosis | HYAL2 | hyaluronidase 2 | 0.13 | -0.11 | -0.23 | 0.15 | 0.87 | 47.04 | Detail |
| 131 | Huntington's Disease (HD) | apoptosis | PSMB4 | proteasome 20S subunit beta 4 | -0.37 | 0.14 | -1.4 | 0.15 | 0.87 | 46.71 | Detail |
| 132 | Huntington's Disease (HD) | apoptosis | SIK1 | salt inducible kinase 1 | -0.22 | 0.05 | -2.24 | 0.15 | 0.87 | 46.71 | Detail |
| 133 | Huntington's Disease (HD) | apoptosis | CD3E | CD3 epsilon subunit of T-cell receptor complex | 0.27 | -0.01 | -5.44 | 0.15 | 0.87 | 46.38 | Detail |
| 134 | Huntington's Disease (HD) | apoptosis | ADORA1 | adenosine A1 receptor | 0.3 | -0.03 | -3.46 | 0.16 | 0.87 | 46.05 | Detail |
| 135 | Huntington's Disease (HD) | apoptosis | CX3CR1 | C-X3-C motif chemokine receptor 1 | 0.15 | -0.12 | -0.34 | 0.16 | 0.87 | 46.05 | Detail |
| 136 | Huntington's Disease (HD) | apoptosis | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta | 0.2 | -0.12 | -0.81 | 0.16 | 0.87 | 46.05 | Detail |
| 137 | Huntington's Disease (HD) | apoptosis | LMNA | lamin A/C | 0.3 | -0.03 | -3.44 | 0.16 | 0.87 | 45.72 | Detail |
| 138 | Huntington's Disease (HD) | apoptosis | PIH1D1 | PIH1 domain containing 1 | -0.22 | 0.09 | -1.31 | 0.16 | 0.87 | 45.72 | Detail |
| 139 | Huntington's Disease (HD) | apoptosis | SLC25A4 | solute carrier family 25 member 4 | -0.08 | 0.19 | 1.15 | 0.16 | 0.87 | 45.72 | Detail |
| 140 | Huntington's Disease (HD) | apoptosis | SCG2 | secretogranin II | 0.24 | -0.01 | -4.36 | 0.16 | 0.87 | 45.56 | Detail |
| 141 | Huntington's Disease (HD) | apoptosis | RNASE1 | ribonuclease A family member 1, pancreatic | -0.22 | 0.17 | -0.41 | 0.16 | 0.87 | 45.39 | Detail |
| 142 | Huntington's Disease (HD) | apoptosis | SLC35F6 | solute carrier family 35 member F6 | 0.18 | -0.1 | -0.89 | 0.16 | 0.87 | 45.39 | Detail |
| 143 | Huntington's Disease (HD) | apoptosis | IL1B | interleukin 1 beta | -0.18 | 0.11 | -0.73 | 0.17 | 0.87 | 45.07 | Detail |
| 144 | Huntington's Disease (HD) | apoptosis | BMP5 | bone morphogenetic protein 5 | 0.27 | -0.03 | -3.11 | 0.17 | 0.87 | 45.07 | Detail |
| 145 | Huntington's Disease (HD) | apoptosis | ARL6IP5 | ADP ribosylation factor like GTPase 6 interacting protein 5 | 0.12 | -0.17 | 0.5 | 0.17 | 0.87 | 45.07 | Detail |
| 146 | Huntington's Disease (HD) | apoptosis | YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | 0.15 | -0.08 | -0.94 | 0.17 | 0.87 | 45.07 | Detail |
| 147 | Huntington's Disease (HD) | apoptosis | ZFYVE9 | zinc finger FYVE-type containing 9 | -0.03 | 0.2 | 2.92 | 0.17 | 0.87 | 44.74 | Detail |
| 148 | Huntington's Disease (HD) | apoptosis | CASP5 | caspase 5 | -0.14 | 0.19 | 0.44 | 0.17 | 0.87 | 44.74 | Detail |
| 149 | Huntington's Disease (HD) | apoptosis | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | 0.26 | -0.01 | -4.51 | 0.17 | 0.87 | 44.74 | Detail |
| 150 | Huntington's Disease (HD) | apoptosis | TMEM117 | transmembrane protein 117 | 0.13 | -0.06 | -1.06 | 0.17 | 0.87 | 44.41 | Detail |
| 151 | Huntington's Disease (HD) | apoptosis | PSMA4 | proteasome 20S subunit alpha 4 | -0.21 | 0.08 | -1.38 | 0.17 | 0.87 | 44.41 | Detail |
| 152 | Huntington's Disease (HD) | apoptosis | PTPN2 | protein tyrosine phosphatase non-receptor type 2 | -0.3 | 0.01 | -4.76 | 0.17 | 0.87 | 44.41 | Detail |
| 153 | Huntington's Disease (HD) | apoptosis | PRKCB | protein kinase C beta | -0.24 | -0.03 | -3.03 | 0.17 | 0.87 | 44.08 | Detail |
| 154 | Huntington's Disease (HD) | apoptosis | E2F1 | E2F transcription factor 1 | 0.14 | -0.15 | 0.04 | 0.17 | 0.87 | 44.08 | Detail |
| 155 | Huntington's Disease (HD) | apoptosis | ITGA5 | integrin subunit alpha 5 | 0.19 | -0.05 | -1.89 | 0.17 | 0.87 | 44.08 | Detail |
| 156 | Huntington's Disease (HD) | apoptosis | STK11 | serine/threonine kinase 11 | 0.41 | -0.04 | -3.5 | 0.17 | 0.87 | 44.08 | Detail |
| 157 | Huntington's Disease (HD) | apoptosis | CUL2 | cullin 2 | -0.23 | 0.07 | -1.65 | 0.17 | 0.87 | 44.08 | Detail |
| 158 | Huntington's Disease (HD) | apoptosis | PIAS4 | protein inhibitor of activated STAT 4 | 0.22 | -0.14 | -0.66 | 0.17 | 0.87 | 44.08 | Detail |
| 159 | Huntington's Disease (HD) | apoptosis | DFFB | DNA fragmentation factor subunit beta | -0.22 | 0.02 | -3.7 | 0.18 | 0.87 | 43.75 | Detail |
| 160 | Huntington's Disease (HD) | apoptosis | AKT2 | AKT serine/threonine kinase 2 | -0.1 | 0.2 | 1.03 | 0.18 | 0.87 | 43.75 | Detail |
| 161 | Huntington's Disease (HD) | apoptosis | RAC3 | Rac family small GTPase 3 | 0.22 | 0.05 | -2.21 | 0.18 | 0.87 | 43.75 | Detail |
| 162 | Huntington's Disease (HD) | apoptosis | DNM1L | dynamin 1 like | -0.37 | 0.09 | -2.06 | 0.18 | 0.87 | 43.75 | Detail |
| 163 | Huntington's Disease (HD) | apoptosis | PPIF | peptidylprolyl isomerase F | -0.22 | 0.02 | -3.25 | 0.18 | 0.87 | 43.75 | Detail |
| 164 | Huntington's Disease (HD) | apoptosis | STYXL1 | serine/threonine/tyrosine interacting like 1 | -0.17 | 0.16 | -0.12 | 0.18 | 0.87 | 43.75 | Detail |
| 165 | Huntington's Disease (HD) | apoptosis | HSPB1 | heat shock protein family B (small) member 1 | 0.24 | -0.02 | -3.29 | 0.18 | 0.87 | 43.42 | Detail |
| 166 | Huntington's Disease (HD) | apoptosis | PSME3 | proteasome activator subunit 3 | 0.18 | -0.17 | -0.14 | 0.18 | 0.87 | 43.42 | Detail |
| 167 | Huntington's Disease (HD) | apoptosis | PRKCA | protein kinase C alpha | 0.3 | -0.01 | -4.63 | 0.18 | 0.87 | 43.42 | Detail |
| 168 | Huntington's Disease (HD) | apoptosis | CASP9 | caspase 9 | -0.18 | 0.1 | -0.83 | 0.18 | 0.87 | 43.42 | Detail |
| 169 | Huntington's Disease (HD) | apoptosis | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | -0.23 | 0.04 | -2.49 | 0.18 | 0.87 | 43.42 | Detail |
| 170 | Huntington's Disease (HD) | apoptosis | P2RX6 | purinergic receptor P2X 6 | 0.23 | -0.01 | -4.75 | 0.18 | 0.87 | 43.42 | Detail |
| 171 | Huntington's Disease (HD) | apoptosis | CTNNB1 | catenin beta 1 | -0.27 | 0.02 | -3.66 | 0.18 | 0.87 | 43.42 | Detail |
| 172 | Huntington's Disease (HD) | apoptosis | PPP1R15A | protein phosphatase 1 regulatory subunit 15A | 0.1 | -0.11 | 0.08 | 0.18 | 0.87 | 43.42 | Detail |
| 173 | Huntington's Disease (HD) | apoptosis | SENP1 | SUMO specific peptidase 1 | -0.13 | 0.18 | 0.47 | 0.18 | 0.87 | 43.42 | Detail |
| 174 | Huntington's Disease (HD) | apoptosis | SIAH2 | siah E3 ubiquitin protein ligase 2 | 0.34 | -0.11 | -1.63 | 0.18 | 0.87 | 43.42 | Detail |
| 175 | Huntington's Disease (HD) | apoptosis | PSMD1 | proteasome 26S subunit, non-ATPase 1 | 0.27 | -0.12 | -1.22 | 0.18 | 0.87 | 43.09 | Detail |
| 176 | Huntington's Disease (HD) | apoptosis | NGFR | nerve growth factor receptor | -0.17 | 0.17 | -0.05 | 0.18 | 0.87 | 43.09 | Detail |
| 177 | Huntington's Disease (HD) | apoptosis | PPARD | peroxisome proliferator activated receptor delta | -0.15 | 0.23 | 0.58 | 0.18 | 0.87 | 43.09 | Detail |
| 178 | Huntington's Disease (HD) | apoptosis | EDA2R | ectodysplasin A2 receptor | -0.11 | 0.21 | 0.91 | 0.19 | 0.88 | 42.76 | Detail |
| 179 | Huntington's Disease (HD) | apoptosis | NDUFA13 | NADH:ubiquinone oxidoreductase subunit A13 | -0.19 | 0.13 | -0.57 | 0.19 | 0.88 | 42.43 | Detail |
| 180 | Huntington's Disease (HD) | apoptosis | BID | BH3 interacting domain death agonist | 0.15 | -0.18 | 0.25 | 0.19 | 0.88 | 42.43 | Detail |
| 181 | Huntington's Disease (HD) | apoptosis | HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.13 | -0.07 | -0.79 | 0.19 | 0.88 | 42.43 | Detail |
| 182 | Huntington's Disease (HD) | apoptosis | TP73 | tumor protein p73 | 0.28 | -0.05 | -2.5 | 0.19 | 0.88 | 42.43 | Detail |
| 183 | Huntington's Disease (HD) | apoptosis | FGF6 | fibroblast growth factor 6 | 0.3 | 0.06 | -2.28 | 0.19 | 0.88 | 42.11 | Detail |
| 184 | Huntington's Disease (HD) | apoptosis | IL3 | interleukin 3 | 0.31 | 0.01 | -5.46 | 0.2 | 0.88 | 41.78 | Detail |
| 185 | Huntington's Disease (HD) | apoptosis | PSMD6 | proteasome 26S subunit, non-ATPase 6 | -0.31 | 0.09 | -1.76 | 0.2 | 0.88 | 41.78 | Detail |
| 186 | Huntington's Disease (HD) | apoptosis | ING5 | inhibitor of growth family member 5 | 0.19 | -0.06 | -1.66 | 0.2 | 0.88 | 41.78 | Detail |
| 187 | Huntington's Disease (HD) | apoptosis | TXNDC12 | thioredoxin domain containing 12 | 0.08 | -0.18 | 1.14 | 0.2 | 0.88 | 41.78 | Detail |
| 188 | Huntington's Disease (HD) | apoptosis | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 0.07 | -0.15 | 1.13 | 0.2 | 0.88 | 41.78 | Detail |
| 189 | Huntington's Disease (HD) | apoptosis | BOK | BCL2 family apoptosis regulator BOK | 0.24 | -0.07 | -1.7 | 0.21 | 0.89 | 41.12 | Detail |
| 190 | Huntington's Disease (HD) | apoptosis | MIF | macrophage migration inhibitory factor | -0.08 | 0.14 | 0.84 | 0.21 | 0.89 | 41.12 | Detail |
| 191 | Huntington's Disease (HD) | apoptosis | PRKDC | protein kinase, DNA-activated, catalytic subunit | -0.17 | 0.19 | 0.17 | 0.21 | 0.89 | 41.12 | Detail |
| 192 | Huntington's Disease (HD) | apoptosis | QRICH1 | glutamine rich 1 | -0.25 | 0.08 | -1.55 | 0.21 | 0.89 | 41.12 | Detail |
| 193 | Huntington's Disease (HD) | apoptosis | HIP1R | huntingtin interacting protein 1 related | -0.11 | 0.16 | 0.54 | 0.21 | 0.9 | 40.79 | Detail |
| 194 | Huntington's Disease (HD) | apoptosis | KITLG | KIT ligand | -0.18 | 0.17 | -0.07 | 0.21 | 0.9 | 40.79 | Detail |
| 195 | Huntington's Disease (HD) | apoptosis | JMY | junction mediating and regulatory protein, p53 cofactor | -0.11 | 0.11 | -0.04 | 0.21 | 0.91 | 40.46 | Detail |
| 196 | Huntington's Disease (HD) | apoptosis | CUL3 | cullin 3 | -0.24 | 0.05 | -2.22 | 0.22 | 0.92 | 40.13 | Detail |
| 197 | Huntington's Disease (HD) | apoptosis | JAK2 | Janus kinase 2 | -0.28 | -0.11 | -1.39 | 0.22 | 0.92 | 40.13 | Detail |
| 198 | Huntington's Disease (HD) | apoptosis | SMAD5 | SMAD family member 5 | 0.03 | -0.17 | 2.71 | 0.22 | 0.92 | 39.8 | Detail |
| 199 | Huntington's Disease (HD) | apoptosis | ZBTB14 | zinc finger and BTB domain containing 14 | -0.22 | 0.04 | -2.35 | 0.22 | 0.92 | 39.8 | Detail |
| 200 | Huntington's Disease (HD) | apoptosis | SHH | sonic hedgehog signaling molecule | 0.3 | -0.0 | -6.56 | 0.22 | 0.92 | 39.8 | Detail |
| 201 | Huntington's Disease (HD) | apoptosis | SNW1 | SNW domain containing 1 | -0.24 | 0.04 | -2.66 | 0.22 | 0.92 | 39.8 | Detail |
| 202 | Huntington's Disease (HD) | apoptosis | RAC2 | Rac family small GTPase 2 | -0.24 | 0.05 | -2.22 | 0.22 | 0.92 | 39.47 | Detail |
| 203 | Huntington's Disease (HD) | apoptosis | ERP29 | endoplasmic reticulum protein 29 | -0.25 | 0.1 | -1.25 | 0.22 | 0.92 | 39.47 | Detail |
| 204 | Huntington's Disease (HD) | apoptosis | WNT4 | Wnt family member 4 | 0.25 | -0.02 | -3.42 | 0.22 | 0.92 | 39.47 | Detail |
| 205 | Huntington's Disease (HD) | apoptosis | IRAK3 | interleukin 1 receptor associated kinase 3 | -0.19 | 0.1 | -0.98 | 0.23 | 0.93 | 39.14 | Detail |
| 206 | Huntington's Disease (HD) | apoptosis | SNAI2 | snail family transcriptional repressor 2 | -0.18 | 0.1 | -0.82 | 0.23 | 0.93 | 39.14 | Detail |
| 207 | Huntington's Disease (HD) | apoptosis | IKBKG | inhibitor of nuclear factor kappa B kinase regulatory subunit gamma | 0.11 | -0.07 | -0.55 | 0.23 | 0.93 | 38.82 | Detail |
| 208 | Huntington's Disease (HD) | apoptosis | MOAP1 | modulator of apoptosis 1 | 0.2 | -0.04 | -2.3 | 0.23 | 0.93 | 38.82 | Detail |
| 209 | Huntington's Disease (HD) | apoptosis | PIK3R2 | phosphoinositide-3-kinase regulatory subunit 2 | 0.37 | -0.11 | -1.8 | 0.24 | 0.94 | 38.49 | Detail |
| 210 | Huntington's Disease (HD) | apoptosis | CASP2 | caspase 2 | -0.19 | 0.12 | -0.68 | 0.24 | 0.94 | 38.49 | Detail |
| 211 | Huntington's Disease (HD) | apoptosis | ST20 | suppressor of tumorigenicity 20 | 0.19 | -0.14 | -0.44 | 0.24 | 0.94 | 38.49 | Detail |
| 212 | Huntington's Disease (HD) | apoptosis | TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.13 | -0.12 | -0.08 | 0.24 | 0.94 | 38.16 | Detail |
| 213 | Huntington's Disease (HD) | apoptosis | PLA2G5 | phospholipase A2 group V | 0.2 | -0.04 | -2.4 | 0.24 | 0.94 | 37.83 | Detail |
| 214 | Huntington's Disease (HD) | apoptosis | HIC1 | HIC ZBTB transcriptional repressor 1 | 0.21 | -0.1 | -1.11 | 0.24 | 0.94 | 37.83 | Detail |
| 215 | Huntington's Disease (HD) | apoptosis | P4HB | prolyl 4-hydroxylase subunit beta | -0.33 | 0.02 | -4.41 | 0.24 | 0.94 | 37.83 | Detail |
| 216 | Huntington's Disease (HD) | apoptosis | USP28 | ubiquitin specific peptidase 28 | -0.26 | 0.14 | -0.88 | 0.24 | 0.94 | 37.83 | Detail |
| 217 | Huntington's Disease (HD) | apoptosis | APP | amyloid beta precursor protein | 0.21 | -0.05 | -2.19 | 0.25 | 0.94 | 37.5 | Detail |
| 218 | Huntington's Disease (HD) | apoptosis | PRKCG | protein kinase C gamma | 0.21 | -0.06 | -1.75 | 0.25 | 0.94 | 37.5 | Detail |
| 219 | Huntington's Disease (HD) | apoptosis | HYOU1 | hypoxia up-regulated 1 | 0.22 | -0.12 | -0.92 | 0.25 | 0.94 | 37.5 | Detail |
| 220 | Huntington's Disease (HD) | apoptosis | PHLDA3 | pleckstrin homology like domain family A member 3 | 0.24 | -0.01 | -5.15 | 0.25 | 0.94 | 37.5 | Detail |
| 221 | Huntington's Disease (HD) | apoptosis | ZMYND11 | zinc finger MYND-type containing 11 | -0.21 | 0.02 | -3.61 | 0.25 | 0.94 | 37.5 | Detail |
| 222 | Huntington's Disease (HD) | apoptosis | FYN | FYN proto-oncogene, Src family tyrosine kinase | -0.11 | 0.08 | -0.4 | 0.25 | 0.95 | 37.17 | Detail |
| 223 | Huntington's Disease (HD) | apoptosis | TERT | telomerase reverse transcriptase | 0.17 | 0.01 | -3.71 | 0.26 | 0.95 | 36.84 | Detail |
| 224 | Huntington's Disease (HD) | apoptosis | CASP8 | caspase 8 | 0.23 | -0.05 | -2.36 | 0.26 | 0.95 | 36.51 | Detail |
| 225 | Huntington's Disease (HD) | apoptosis | NTRK1 | neurotrophic receptor tyrosine kinase 1 | 0.09 | -0.14 | 0.61 | 0.26 | 0.95 | 36.51 | Detail |
| 226 | Huntington's Disease (HD) | apoptosis | SPHK1 | sphingosine kinase 1 | 0.18 | -0.18 | 0.03 | 0.26 | 0.95 | 36.51 | Detail |
| 227 | Huntington's Disease (HD) | apoptosis | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | -0.21 | 0.01 | -5.11 | 0.26 | 0.95 | 36.51 | Detail |
| 228 | Huntington's Disease (HD) | apoptosis | MFF | mitochondrial fission factor | -0.18 | 0.07 | -1.28 | 0.26 | 0.95 | 36.51 | Detail |
| 229 | Huntington's Disease (HD) | apoptosis | VNN1 | vanin 1 | -0.16 | 0.06 | -1.47 | 0.26 | 0.95 | 36.51 | Detail |
| 230 | Huntington's Disease (HD) | apoptosis | WWOX | WW domain containing oxidoreductase | -0.1 | 0.12 | 0.16 | 0.26 | 0.95 | 36.51 | Detail |
| 231 | Huntington's Disease (HD) | apoptosis | RBL2 | RB transcriptional corepressor like 2 | 0.19 | -0.04 | -2.24 | 0.27 | 0.95 | 36.18 | Detail |
| 232 | Huntington's Disease (HD) | apoptosis | INS | insulin | 0.28 | 0.03 | -3.28 | 0.27 | 0.95 | 36.18 | Detail |
| 233 | Huntington's Disease (HD) | apoptosis | PPIA | peptidylprolyl isomerase A | 0.22 | -0.07 | -1.72 | 0.27 | 0.95 | 36.18 | Detail |
| 234 | Huntington's Disease (HD) | apoptosis | MAPK13 | mitogen-activated protein kinase 13 | -0.11 | 0.1 | -0.08 | 0.27 | 0.96 | 35.86 | Detail |
| 235 | Huntington's Disease (HD) | apoptosis | FZD9 | frizzled class receptor 9 | 0.3 | 0.02 | -3.74 | 0.27 | 0.96 | 35.86 | Detail |
| 236 | Huntington's Disease (HD) | apoptosis | UBE4B | ubiquitination factor E4B | -0.14 | 0.09 | -0.58 | 0.27 | 0.96 | 35.86 | Detail |
| 237 | Huntington's Disease (HD) | apoptosis | CUL1 | cullin 1 | -0.14 | 0.06 | -1.21 | 0.27 | 0.96 | 35.53 | Detail |
| 238 | Huntington's Disease (HD) | apoptosis | FGA | fibrinogen alpha chain | 0.33 | 0.05 | -2.85 | 0.27 | 0.96 | 35.53 | Detail |
| 239 | Huntington's Disease (HD) | apoptosis | SSTR3 | somatostatin receptor 3 | 0.25 | 0.12 | -1.07 | 0.27 | 0.96 | 35.53 | Detail |
| 240 | Huntington's Disease (HD) | apoptosis | CRYBA1 | crystallin beta A1 | -0.11 | 0.04 | -1.34 | 0.28 | 0.96 | 35.2 | Detail |
| 241 | Huntington's Disease (HD) | apoptosis | CIB1 | calcium and integrin binding 1 | -0.27 | 0.06 | -2.08 | 0.28 | 0.96 | 35.2 | Detail |
| 242 | Huntington's Disease (HD) | apoptosis | IL20RA | interleukin 20 receptor subunit alpha | 0.3 | -0.05 | -2.5 | 0.28 | 0.96 | 34.87 | Detail |
| 243 | Huntington's Disease (HD) | apoptosis | RNF186 | ring finger protein 186 | 0.26 | 0.02 | -3.87 | 0.28 | 0.96 | 34.87 | Detail |
| 244 | Huntington's Disease (HD) | apoptosis | DIABLO | diablo IAP-binding mitochondrial protein | -0.18 | 0.07 | -1.43 | 0.29 | 0.96 | 34.54 | Detail |
| 245 | Huntington's Disease (HD) | apoptosis | CHP1 | calcineurin like EF-hand protein 1 | 0.17 | -0.11 | -0.7 | 0.29 | 0.96 | 34.54 | Detail |
| 246 | Huntington's Disease (HD) | apoptosis | DAPK1 | death associated protein kinase 1 | 0.14 | -0.07 | -1.05 | 0.29 | 0.96 | 34.54 | Detail |
| 247 | Huntington's Disease (HD) | apoptosis | ERN2 | endoplasmic reticulum to nucleus signaling 2 | 0.23 | 0.04 | -2.53 | 0.29 | 0.96 | 34.54 | Detail |
| 248 | Huntington's Disease (HD) | apoptosis | FGF10 | fibroblast growth factor 10 | 0.13 | -0.11 | -0.17 | 0.29 | 0.96 | 34.54 | Detail |
| 249 | Huntington's Disease (HD) | apoptosis | GATA4 | GATA binding protein 4 | 0.29 | 0.05 | -2.41 | 0.29 | 0.96 | 34.54 | Detail |
| 250 | Huntington's Disease (HD) | apoptosis | S100A9 | S100 calcium binding protein A9 | -0.12 | 0.08 | -0.53 | 0.29 | 0.96 | 34.54 | Detail |
| 251 | Huntington's Disease (HD) | apoptosis | PSMD12 | proteasome 26S subunit, non-ATPase 12 | -0.28 | 0.0 | -6.61 | 0.29 | 0.96 | 34.21 | Detail |
| 252 | Huntington's Disease (HD) | apoptosis | BRSK2 | BR serine/threonine kinase 2 | 0.32 | 0.06 | -2.5 | 0.29 | 0.96 | 34.21 | Detail |
| 253 | Huntington's Disease (HD) | apoptosis | CD27 | CD27 molecule | -0.12 | 0.14 | 0.26 | 0.29 | 0.96 | 34.21 | Detail |
| 254 | Huntington's Disease (HD) | apoptosis | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | -0.15 | -0.0 | -6.73 | 0.3 | 0.96 | 33.88 | Detail |
| 255 | Huntington's Disease (HD) | apoptosis | CHRD | chordin | 0.25 | -0.01 | -5.08 | 0.3 | 0.96 | 33.88 | Detail |
| 256 | Huntington's Disease (HD) | apoptosis | IL12A | interleukin 12A | -0.21 | 0.0 | -6.27 | 0.3 | 0.96 | 33.88 | Detail |
| 257 | Huntington's Disease (HD) | apoptosis | ITGAM | integrin subunit alpha M | 0.08 | -0.11 | 0.41 | 0.3 | 0.96 | 33.88 | Detail |
| 258 | Huntington's Disease (HD) | apoptosis | NUPR1 | nuclear protein 1, transcriptional regulator | 0.19 | 0.05 | -1.83 | 0.3 | 0.96 | 33.88 | Detail |
| 259 | Huntington's Disease (HD) | apoptosis | UBE2K | ubiquitin conjugating enzyme E2 K | 0.0 | -0.11 | 5.31 | 0.3 | 0.96 | 33.88 | Detail |
| 260 | Huntington's Disease (HD) | apoptosis | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | -0.12 | 0.05 | -1.32 | 0.3 | 0.96 | 33.55 | Detail |
| 261 | Huntington's Disease (HD) | apoptosis | SKP1 | S-phase kinase associated protein 1 | 0.18 | -0.08 | -1.14 | 0.3 | 0.96 | 33.55 | Detail |
| 262 | Huntington's Disease (HD) | apoptosis | CDKN2D | cyclin dependent kinase inhibitor 2D | 0.08 | -0.1 | 0.28 | 0.3 | 0.96 | 33.55 | Detail |
| 263 | Huntington's Disease (HD) | apoptosis | ATM | ATM serine/threonine kinase | -0.32 | 0.11 | -1.49 | 0.31 | 0.97 | 33.22 | Detail |
| 264 | Huntington's Disease (HD) | apoptosis | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | -0.26 | -0.06 | -2.21 | 0.31 | 0.97 | 33.22 | Detail |
| 265 | Huntington's Disease (HD) | apoptosis | SLC9A3R1 | NHERF family PDZ scaffold protein 1 | 0.21 | -0.03 | -2.92 | 0.31 | 0.97 | 33.22 | Detail |
| 266 | Huntington's Disease (HD) | apoptosis | CWC27 | CWC27 spliceosome associated cyclophilin | -0.15 | 0.01 | -3.94 | 0.31 | 0.97 | 32.89 | Detail |
| 267 | Huntington's Disease (HD) | apoptosis | CSNK2A1 | casein kinase 2 alpha 1 | 0.26 | -0.06 | -2.23 | 0.31 | 0.97 | 32.89 | Detail |
| 268 | Huntington's Disease (HD) | apoptosis | MAPKAPK2 | MAPK activated protein kinase 2 | 0.13 | -0.11 | -0.23 | 0.32 | 0.97 | 32.57 | Detail |
| 269 | Huntington's Disease (HD) | apoptosis | ARRB2 | arrestin beta 2 | 0.28 | -0.05 | -2.4 | 0.32 | 0.97 | 32.57 | Detail |
| 270 | Huntington's Disease (HD) | apoptosis | FGFR3 | fibroblast growth factor receptor 3 | 0.21 | -0.02 | -3.18 | 0.32 | 0.97 | 32.57 | Detail |
| 271 | Huntington's Disease (HD) | apoptosis | PLAUR | plasminogen activator, urokinase receptor | -0.17 | 0.01 | -4.28 | 0.32 | 0.97 | 32.57 | Detail |
| 272 | Huntington's Disease (HD) | apoptosis | PYCARD | PYD and CARD domain containing | -0.13 | 0.0 | -5.12 | 0.32 | 0.97 | 32.57 | Detail |
| 273 | Huntington's Disease (HD) | apoptosis | C5 | complement C5 | -0.23 | 0.02 | -3.57 | 0.32 | 0.98 | 32.24 | Detail |
| 274 | Huntington's Disease (HD) | apoptosis | TOP1 | DNA topoisomerase I | 0.13 | -0.11 | -0.26 | 0.32 | 0.98 | 32.24 | Detail |
| 275 | Huntington's Disease (HD) | apoptosis | MKNK2 | MAPK interacting serine/threonine kinase 2 | 0.24 | -0.03 | -3.13 | 0.32 | 0.98 | 32.24 | Detail |
| 276 | Huntington's Disease (HD) | apoptosis | MAPKAPK3 | MAPK activated protein kinase 3 | 0.13 | -0.06 | -1.06 | 0.33 | 0.98 | 31.91 | Detail |
| 277 | Huntington's Disease (HD) | apoptosis | CAAP1 | caspase activity and apoptosis inhibitor 1 | 0.04 | -0.1 | 1.45 | 0.33 | 0.98 | 31.91 | Detail |
| 278 | Huntington's Disease (HD) | apoptosis | PSMA3 | proteasome 20S subunit alpha 3 | -0.33 | -0.02 | -4.02 | 0.33 | 0.98 | 31.91 | Detail |
| 279 | Huntington's Disease (HD) | apoptosis | MSH2 | mutS homolog 2 | -0.1 | 0.04 | -1.25 | 0.33 | 0.98 | 31.91 | Detail |
| 280 | Huntington's Disease (HD) | apoptosis | ACTA1 | actin alpha 1, skeletal muscle | 0.34 | 0.01 | -4.55 | 0.33 | 0.98 | 31.58 | Detail |
| 281 | Huntington's Disease (HD) | apoptosis | BCL2L14 | BCL2 like 14 | 0.11 | -0.11 | -0.1 | 0.33 | 0.98 | 31.58 | Detail |
| 282 | Huntington's Disease (HD) | apoptosis | MSH6 | mutS homolog 6 | -0.11 | 0.13 | 0.27 | 0.33 | 0.98 | 31.58 | Detail |
| 283 | Huntington's Disease (HD) | apoptosis | SLC25A6 | solute carrier family 25 member 6 | -0.16 | 0.08 | -0.92 | 0.33 | 0.98 | 31.58 | Detail |
| 284 | Huntington's Disease (HD) | apoptosis | TGFB1 | transforming growth factor beta 1 | 0.11 | -0.06 | -0.97 | 0.34 | 0.98 | 31.25 | Detail |
| 285 | Huntington's Disease (HD) | apoptosis | FGG | fibrinogen gamma chain | -0.15 | 0.13 | -0.22 | 0.34 | 0.98 | 31.25 | Detail |
| 286 | Huntington's Disease (HD) | apoptosis | TP53BP2 | tumor protein p53 binding protein 2 | 0.05 | -0.2 | 1.92 | 0.34 | 0.98 | 31.25 | Detail |
| 287 | Huntington's Disease (HD) | apoptosis | PSMB9 | proteasome 20S subunit beta 9 | -0.18 | 0.06 | -1.44 | 0.34 | 0.98 | 30.92 | Detail |
| 288 | Huntington's Disease (HD) | apoptosis | OAZ3 | ornithine decarboxylase antizyme 3 | -0.05 | 0.16 | 1.73 | 0.34 | 0.98 | 30.92 | Detail |
| 289 | Huntington's Disease (HD) | apoptosis | PSEN1 | presenilin 1 | -0.28 | -0.02 | -3.5 | 0.34 | 0.98 | 30.92 | Detail |
| 290 | Huntington's Disease (HD) | apoptosis | SFN | stratifin | 0.34 | -0.02 | -4.21 | 0.34 | 0.98 | 30.92 | Detail |
| 291 | Huntington's Disease (HD) | apoptosis | NFATC3 | nuclear factor of activated T cells 3 | 0.09 | 0.01 | -2.79 | 0.35 | 0.99 | 30.59 | Detail |
| 292 | Huntington's Disease (HD) | apoptosis | CCAR2 | cell cycle and apoptosis regulator 2 | -0.07 | 0.05 | -0.65 | 0.35 | 0.99 | 30.59 | Detail |
| 293 | Huntington's Disease (HD) | apoptosis | CFLAR | CASP8 and FADD like apoptosis regulator | -0.06 | 0.04 | -0.69 | 0.35 | 0.99 | 30.26 | Detail |
| 294 | Huntington's Disease (HD) | apoptosis | BMP4 | bone morphogenetic protein 4 | 0.28 | 0.0 | -7.33 | 0.36 | 0.99 | 29.93 | Detail |
| 295 | Huntington's Disease (HD) | apoptosis | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.19 | -0.04 | -2.17 | 0.36 | 0.99 | 29.93 | Detail |
| 296 | Huntington's Disease (HD) | apoptosis | ACKR3 | atypical chemokine receptor 3 | 0.11 | -0.03 | -1.88 | 0.36 | 0.99 | 29.93 | Detail |
| 297 | Huntington's Disease (HD) | apoptosis | MAPK11 | mitogen-activated protein kinase 11 | -0.02 | 0.17 | 3.17 | 0.36 | 0.99 | 29.61 | Detail |
| 298 | Huntington's Disease (HD) | apoptosis | PTGIS | prostaglandin I2 synthase | -0.22 | 0.08 | -1.52 | 0.36 | 0.99 | 29.61 | Detail |
| 299 | Huntington's Disease (HD) | apoptosis | LMNB2 | lamin B2 | 0.09 | -0.03 | -1.77 | 0.37 | 0.99 | 29.44 | Detail |
| 300 | Huntington's Disease (HD) | apoptosis | AKT1 | AKT serine/threonine kinase 1 | 0.13 | -0.1 | -0.41 | 0.37 | 0.99 | 29.28 | Detail |
| 301 | Huntington's Disease (HD) | apoptosis | PSMD8 | proteasome 26S subunit, non-ATPase 8 | -0.11 | 0.04 | -1.42 | 0.37 | 0.99 | 29.28 | Detail |
| 302 | Huntington's Disease (HD) | apoptosis | SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 0.22 | 0.03 | -2.8 | 0.37 | 0.99 | 29.28 | Detail |
| 303 | Huntington's Disease (HD) | apoptosis | CTSC | cathepsin C | 0.15 | -0.12 | -0.32 | 0.37 | 0.99 | 29.28 | Detail |
| 304 | Huntington's Disease (HD) | apoptosis | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | -0.28 | -0.04 | -2.65 | 0.37 | 0.99 | 29.28 | Detail |
| 305 | Huntington's Disease (HD) | apoptosis | NACC2 | NACC family member 2 | 0.2 | -0.12 | -0.76 | 0.37 | 0.99 | 29.28 | Detail |
| 306 | Huntington's Disease (HD) | apoptosis | TIMM50 | translocase of inner mitochondrial membrane 50 | -0.14 | 0.04 | -1.86 | 0.37 | 0.99 | 29.28 | Detail |
| 307 | Huntington's Disease (HD) | apoptosis | ACVR1 | activin A receptor type 1 | 0.05 | -0.03 | -0.56 | 0.37 | 0.99 | 28.95 | Detail |
| 308 | Huntington's Disease (HD) | apoptosis | SFRP1 | secreted frizzled related protein 1 | 0.26 | -0.08 | -1.6 | 0.37 | 0.99 | 28.95 | Detail |
| 309 | Huntington's Disease (HD) | apoptosis | PDK4 | pyruvate dehydrogenase kinase 4 | -0.18 | 0.07 | -1.38 | 0.37 | 0.99 | 28.95 | Detail |
| 310 | Huntington's Disease (HD) | apoptosis | PSMB7 | proteasome 20S subunit beta 7 | -0.1 | 0.14 | 0.52 | 0.38 | 0.99 | 28.62 | Detail |
| 311 | Huntington's Disease (HD) | apoptosis | SH2D2A | SH2 domain containing 2A | 0.02 | 0.18 | 3.41 | 0.38 | 0.99 | 28.62 | Detail |
| 312 | Huntington's Disease (HD) | apoptosis | IL9 | interleukin 9 | -0.08 | 0.19 | 1.27 | 0.38 | 0.99 | 28.62 | Detail |
| 313 | Huntington's Disease (HD) | apoptosis | P2RX4 | purinergic receptor P2X 4 | 0.1 | -0.12 | 0.17 | 0.38 | 0.99 | 28.62 | Detail |
| 314 | Huntington's Disease (HD) | apoptosis | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.03 | -0.12 | 2.08 | 0.38 | 0.99 | 28.62 | Detail |
| 315 | Huntington's Disease (HD) | apoptosis | RPS6KB1 | ribosomal protein S6 kinase B1 | -0.08 | 0.0 | -4.92 | 0.38 | 0.99 | 28.29 | Detail |
| 316 | Huntington's Disease (HD) | apoptosis | NFATC1 | nuclear factor of activated T cells 1 | 0.1 | 0.0 | -5.93 | 0.38 | 0.99 | 28.29 | Detail |
| 317 | Huntington's Disease (HD) | apoptosis | GDF5 | growth differentiation factor 5 | 0.3 | 0.08 | -1.81 | 0.38 | 0.99 | 28.29 | Detail |
| 318 | Huntington's Disease (HD) | apoptosis | AIFM1 | apoptosis inducing factor mitochondria associated 1 | -0.01 | -0.07 | 3.47 | 0.38 | 0.99 | 28.29 | Detail |
| 319 | Huntington's Disease (HD) | apoptosis | PPP3CC | protein phosphatase 3 catalytic subunit gamma | -0.02 | 0.09 | 2.44 | 0.38 | 0.99 | 28.29 | Detail |
| 320 | Huntington's Disease (HD) | apoptosis | RBCK1 | RANBP2-type and C3HC4-type zinc finger containing 1 | -0.11 | 0.05 | -1.02 | 0.38 | 0.99 | 28.29 | Detail |
| 321 | Huntington's Disease (HD) | apoptosis | PTK2 | protein tyrosine kinase 2 | -0.25 | 0.12 | -1.0 | 0.39 | 0.99 | 27.96 | Detail |
| 322 | Huntington's Disease (HD) | apoptosis | CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | -0.12 | 0.02 | -2.53 | 0.39 | 0.99 | 27.96 | Detail |
| 323 | Huntington's Disease (HD) | apoptosis | MLLT11 | MLLT11 transcription factor 7 cofactor | -0.08 | 0.12 | 0.58 | 0.39 | 0.99 | 27.96 | Detail |
| 324 | Huntington's Disease (HD) | apoptosis | MNT | MAX network transcriptional repressor | 0.21 | -0.06 | -1.8 | 0.39 | 0.99 | 27.96 | Detail |
| 325 | Huntington's Disease (HD) | apoptosis | ENDOG | endonuclease G | -0.08 | 0.12 | 0.53 | 0.4 | 0.99 | 27.63 | Detail |
| 326 | Huntington's Disease (HD) | apoptosis | CAPN2 | calpain 2 | -0.03 | 0.09 | 1.69 | 0.4 | 0.99 | 27.63 | Detail |
| 327 | Huntington's Disease (HD) | apoptosis | FAIM | Fas apoptotic inhibitory molecule | -0.16 | 0.06 | -1.41 | 0.4 | 0.99 | 27.63 | Detail |
| 328 | Huntington's Disease (HD) | apoptosis | ICAM1 | intercellular adhesion molecule 1 | 0.05 | -0.13 | 1.2 | 0.4 | 0.99 | 27.63 | Detail |
| 329 | Huntington's Disease (HD) | apoptosis | FASLG | Fas ligand | 0.19 | -0.08 | -1.26 | 0.4 | 0.99 | 27.3 | Detail |
| 330 | Huntington's Disease (HD) | apoptosis | ACVR2A | activin A receptor type 2A | -0.2 | 0.07 | -1.45 | 0.4 | 0.99 | 27.3 | Detail |
| 331 | Huntington's Disease (HD) | apoptosis | SIGMAR1 | sigma non-opioid intracellular receptor 1 | -0.11 | 0.07 | -0.66 | 0.4 | 0.99 | 27.3 | Detail |
| 332 | Huntington's Disease (HD) | apoptosis | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | -0.14 | 0.07 | -1.0 | 0.4 | 0.99 | 27.3 | Detail |
| 333 | Huntington's Disease (HD) | apoptosis | RHOV | ras homolog family member V | 0.21 | -0.03 | -2.62 | 0.4 | 0.99 | 27.3 | Detail |
| 334 | Huntington's Disease (HD) | apoptosis | DEPTOR | DEP domain containing MTOR interacting protein | 0.01 | 0.17 | 4.46 | 0.4 | 0.99 | 27.3 | Detail |
| 335 | Huntington's Disease (HD) | apoptosis | SRPX | sushi repeat containing protein X-linked | -0.1 | 0.06 | -0.76 | 0.4 | 0.99 | 27.3 | Detail |
| 336 | Huntington's Disease (HD) | apoptosis | TAF9B | TATA-box binding protein associated factor 9b | -0.18 | 0.07 | -1.29 | 0.4 | 0.99 | 27.3 | Detail |
| 337 | Huntington's Disease (HD) | apoptosis | TLR3 | toll like receptor 3 | -0.1 | -0.01 | -3.19 | 0.4 | 0.99 | 27.3 | Detail |
| 338 | Huntington's Disease (HD) | apoptosis | ZSWIM2 | zinc finger SWIM-type containing 2 | 0.27 | -0.06 | -2.22 | 0.4 | 0.99 | 27.3 | Detail |
| 339 | Huntington's Disease (HD) | apoptosis | TP53 | tumor protein p53 | -0.09 | 0.09 | 0.13 | 0.41 | 0.99 | 26.97 | Detail |
| 340 | Huntington's Disease (HD) | apoptosis | BECN1 | beclin 1 | 0.03 | -0.16 | 2.26 | 0.41 | 0.99 | 26.97 | Detail |
| 341 | Huntington's Disease (HD) | apoptosis | DEDD2 | death effector domain containing 2 | 0.11 | -0.06 | -0.77 | 0.41 | 0.99 | 26.97 | Detail |
| 342 | Huntington's Disease (HD) | apoptosis | HMGB2 | high mobility group box 2 | 0.16 | -0.05 | -1.7 | 0.41 | 0.99 | 26.97 | Detail |
| 343 | Huntington's Disease (HD) | apoptosis | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.06 | -0.08 | 0.37 | 0.41 | 0.99 | 26.97 | Detail |
| 344 | Huntington's Disease (HD) | apoptosis | PLA2G2A | phospholipase A2 group IIA | -0.12 | 0.15 | 0.24 | 0.41 | 0.99 | 26.64 | Detail |
| 345 | Huntington's Disease (HD) | apoptosis | SERPINF2 | serpin family F member 2 | 0.08 | -0.08 | -0.09 | 0.41 | 0.99 | 26.64 | Detail |
| 346 | Huntington's Disease (HD) | apoptosis | PSMB2 | proteasome 20S subunit beta 2 | 0.12 | -0.06 | -0.95 | 0.41 | 0.99 | 26.64 | Detail |
| 347 | Huntington's Disease (HD) | apoptosis | PARP1 | poly(ADP-ribose) polymerase 1 | 0.14 | -0.0 | -6.23 | 0.42 | 0.99 | 26.48 | Detail |
| 348 | Huntington's Disease (HD) | apoptosis | TNFRSF10B | TNF receptor superfamily member 10b | 0.09 | -0.12 | 0.47 | 0.42 | 0.99 | 26.32 | Detail |
| 349 | Huntington's Disease (HD) | apoptosis | ARID3B | AT-rich interaction domain 3B | -0.12 | 0.0 | -4.82 | 0.42 | 0.99 | 26.32 | Detail |
| 350 | Huntington's Disease (HD) | apoptosis | P2RX7 | purinergic receptor P2X 7 | -0.07 | -0.2 | 1.56 | 0.42 | 0.99 | 26.32 | Detail |
| 351 | Huntington's Disease (HD) | apoptosis | PSMA7 | proteasome 20S subunit alpha 7 | -0.13 | 0.03 | -1.95 | 0.42 | 0.99 | 25.99 | Detail |
| 352 | Huntington's Disease (HD) | apoptosis | PPP2R1B | protein phosphatase 2 scaffold subunit Abeta | 0.11 | -0.01 | -3.95 | 0.42 | 0.99 | 25.99 | Detail |
| 353 | Huntington's Disease (HD) | apoptosis | DPF2 | double PHD fingers 2 | -0.08 | 0.02 | -1.64 | 0.42 | 0.99 | 25.99 | Detail |
| 354 | Huntington's Disease (HD) | apoptosis | FBXW7 | F-box and WD repeat domain containing 7 | 0.05 | -0.05 | 0.16 | 0.42 | 0.99 | 25.99 | Detail |
| 355 | Huntington's Disease (HD) | apoptosis | MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.06 | -0.08 | 0.41 | 0.42 | 0.99 | 25.99 | Detail |
| 356 | Huntington's Disease (HD) | apoptosis | TRIAP1 | TP53 regulated inhibitor of apoptosis 1 | -0.05 | 0.12 | 1.46 | 0.42 | 0.99 | 25.99 | Detail |
| 357 | Huntington's Disease (HD) | apoptosis | PIK3R3 | phosphoinositide-3-kinase regulatory subunit 3 | -0.01 | -0.11 | 4.33 | 0.43 | 0.99 | 25.66 | Detail |
| 358 | Huntington's Disease (HD) | apoptosis | GHRL | ghrelin and obestatin prepropeptide | 0.12 | -0.1 | -0.24 | 0.43 | 0.99 | 25.66 | Detail |
| 359 | Huntington's Disease (HD) | apoptosis | SGMS1 | sphingomyelin synthase 1 | 0.06 | -0.11 | 0.95 | 0.43 | 0.99 | 25.66 | Detail |
| 360 | Huntington's Disease (HD) | apoptosis | PSMC4 | proteasome 26S subunit, ATPase 4 | -0.1 | 0.09 | -0.26 | 0.43 | 0.99 | 25.66 | Detail |
| 361 | Huntington's Disease (HD) | apoptosis | CHCHD10 | coiled-coil-helix-coiled-coil-helix domain containing 10 | -0.12 | 0.0 | -7.73 | 0.43 | 0.99 | 25.66 | Detail |
| 362 | Huntington's Disease (HD) | apoptosis | SMAD4 | SMAD family member 4 | -0.22 | 0.01 | -4.21 | 0.44 | 0.99 | 25.33 | Detail |
| 363 | Huntington's Disease (HD) | apoptosis | PSMA1 | proteasome 20S subunit alpha 1 | -0.21 | 0.02 | -3.27 | 0.44 | 0.99 | 25.33 | Detail |
| 364 | Huntington's Disease (HD) | apoptosis | PSMB10 | proteasome 20S subunit beta 10 | -0.12 | 0.01 | -3.09 | 0.44 | 0.99 | 25.33 | Detail |
| 365 | Huntington's Disease (HD) | apoptosis | ERBB3 | erb-b2 receptor tyrosine kinase 3 | 0.11 | -0.05 | -1.31 | 0.44 | 0.99 | 25.33 | Detail |
| 366 | Huntington's Disease (HD) | apoptosis | FAS | Fas cell surface death receptor | -0.01 | -0.04 | 2.02 | 0.44 | 0.99 | 25.0 | Detail |
| 367 | Huntington's Disease (HD) | apoptosis | SLK | STE20 like kinase | 0.02 | -0.12 | 2.81 | 0.44 | 0.99 | 25.0 | Detail |
| 368 | Huntington's Disease (HD) | apoptosis | CYLD | CYLD lysine 63 deubiquitinase | -0.14 | 0.01 | -4.03 | 0.44 | 0.99 | 25.0 | Detail |
| 369 | Huntington's Disease (HD) | apoptosis | RNF34 | ring finger protein 34 | 0.09 | -0.0 | -5.11 | 0.44 | 0.99 | 25.0 | Detail |
| 370 | Huntington's Disease (HD) | apoptosis | RELA | RELA proto-oncogene, NF-kB subunit | 0.08 | -0.02 | -2.18 | 0.45 | 0.99 | 24.67 | Detail |
| 371 | Huntington's Disease (HD) | apoptosis | ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.09 | -0.07 | -0.4 | 0.45 | 0.99 | 24.67 | Detail |
| 372 | Huntington's Disease (HD) | apoptosis | AR | androgen receptor | 0.14 | -0.07 | -1.0 | 0.45 | 0.99 | 24.67 | Detail |
| 373 | Huntington's Disease (HD) | apoptosis | MPV17L | MPV17 mitochondrial inner membrane protein like | 0.08 | 0.02 | -2.33 | 0.45 | 0.99 | 24.67 | Detail |
| 374 | Huntington's Disease (HD) | apoptosis | SFRP2 | secreted frizzled related protein 2 | 0.21 | -0.07 | -1.52 | 0.45 | 0.99 | 24.67 | Detail |
| 375 | Huntington's Disease (HD) | apoptosis | PSMD4 | proteasome 26S subunit ubiquitin receptor, non-ATPase 4 | 0.11 | -0.11 | 0.01 | 0.45 | 0.99 | 24.34 | Detail |
| 376 | Huntington's Disease (HD) | apoptosis | CSF2RB | colony stimulating factor 2 receptor subunit beta | 0.09 | -0.09 | -0.08 | 0.45 | 0.99 | 24.34 | Detail |
| 377 | Huntington's Disease (HD) | apoptosis | BCL10 | BCL10 immune signaling adaptor | 0.08 | -0.05 | -0.77 | 0.45 | 0.99 | 24.34 | Detail |
| 378 | Huntington's Disease (HD) | apoptosis | SPI1 | Spi-1 proto-oncogene | -0.12 | 0.01 | -4.01 | 0.45 | 0.99 | 24.34 | Detail |
| 379 | Huntington's Disease (HD) | apoptosis | TRIB3 | tribbles pseudokinase 3 | 0.12 | -0.08 | -0.51 | 0.45 | 0.99 | 24.34 | Detail |
| 380 | Huntington's Disease (HD) | apoptosis | SMAD3 | SMAD family member 3 | -0.14 | 0.06 | -1.29 | 0.46 | 0.99 | 24.01 | Detail |
| 381 | Huntington's Disease (HD) | apoptosis | ANKRD13C | ankyrin repeat domain 13C | -0.01 | -0.09 | 3.46 | 0.46 | 0.99 | 24.01 | Detail |
| 382 | Huntington's Disease (HD) | apoptosis | BCL2L2 | BCL2 like 2 | 0.1 | -0.14 | 0.47 | 0.46 | 0.99 | 24.01 | Detail |
| 383 | Huntington's Disease (HD) | apoptosis | PARK7 | Parkinsonism associated deglycase | 0.14 | -0.04 | -1.86 | 0.46 | 0.99 | 24.01 | Detail |
| 384 | Huntington's Disease (HD) | apoptosis | SOD1 | superoxide dismutase 1 | -0.15 | 0.06 | -1.37 | 0.46 | 0.99 | 24.01 | Detail |
| 385 | Huntington's Disease (HD) | apoptosis | ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 0.15 | -0.09 | -0.69 | 0.47 | 0.99 | 23.68 | Detail |
| 386 | Huntington's Disease (HD) | apoptosis | MEIS3 | Meis homeobox 3 | 0.25 | 0.04 | -2.54 | 0.47 | 0.99 | 23.68 | Detail |
| 387 | Huntington's Disease (HD) | apoptosis | POU4F2 | POU class 4 homeobox 2 | 0.19 | -0.06 | -1.6 | 0.47 | 0.99 | 23.68 | Detail |
| 388 | Huntington's Disease (HD) | apoptosis | PPM1F | protein phosphatase, Mg2+/Mn2+ dependent 1F | 0.17 | -0.04 | -2.24 | 0.47 | 0.99 | 23.68 | Detail |
| 389 | Huntington's Disease (HD) | apoptosis | RPS6KB2 | ribosomal protein S6 kinase B2 | 0.21 | -0.02 | -3.84 | 0.47 | 0.99 | 23.36 | Detail |
| 390 | Huntington's Disease (HD) | apoptosis | TNFRSF10A | TNF receptor superfamily member 10a | -0.06 | 0.06 | 0.13 | 0.47 | 0.99 | 23.36 | Detail |
| 391 | Huntington's Disease (HD) | apoptosis | BCL2L10 | BCL2 like 10 | 0.07 | 0.01 | -2.68 | 0.47 | 0.99 | 23.36 | Detail |
| 392 | Huntington's Disease (HD) | apoptosis | IL1R1 | interleukin 1 receptor type 1 | -0.02 | 0.03 | 0.98 | 0.48 | 0.99 | 23.03 | Detail |
| 393 | Huntington's Disease (HD) | apoptosis | ID4 | inhibitor of DNA binding 4 | 0.04 | 0.08 | 0.87 | 0.48 | 0.99 | 23.03 | Detail |
| 394 | Huntington's Disease (HD) | apoptosis | DAP | death associated protein | 0.08 | -0.05 | -0.67 | 0.48 | 0.99 | 23.03 | Detail |
| 395 | Huntington's Disease (HD) | apoptosis | EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 | 0.14 | -0.06 | -1.26 | 0.48 | 0.99 | 23.03 | Detail |
| 396 | Huntington's Disease (HD) | apoptosis | RB1 | RB transcriptional corepressor 1 | -0.16 | -0.03 | -2.47 | 0.48 | 0.99 | 23.03 | Detail |
| 397 | Huntington's Disease (HD) | apoptosis | SERINC3 | serine incorporator 3 | 0.15 | -0.03 | -2.29 | 0.48 | 0.99 | 23.03 | Detail |
| 398 | Huntington's Disease (HD) | apoptosis | STK4 | serine/threonine kinase 4 | -0.22 | -0.01 | -4.27 | 0.48 | 0.99 | 23.03 | Detail |
| 399 | Huntington's Disease (HD) | apoptosis | TMEM109 | transmembrane protein 109 | 0.12 | -0.04 | -1.47 | 0.48 | 0.99 | 23.03 | Detail |
| 400 | Huntington's Disease (HD) | apoptosis | ABO | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.22 | -0.06 | -1.81 | 0.49 | 0.99 | 22.7 | Detail |
| 401 | Huntington's Disease (HD) | apoptosis | RIPK1 | receptor interacting serine/threonine kinase 1 | 0.14 | -0.05 | -1.49 | 0.49 | 0.99 | 22.7 | Detail |
| 402 | Huntington's Disease (HD) | apoptosis | PSMD14 | proteasome 26S subunit, non-ATPase 14 | 0.16 | -0.05 | -1.76 | 0.49 | 0.99 | 22.7 | Detail |
| 403 | Huntington's Disease (HD) | apoptosis | MAPK7 | mitogen-activated protein kinase 7 | 0.11 | -0.04 | -1.35 | 0.49 | 0.99 | 22.7 | Detail |
| 404 | Huntington's Disease (HD) | apoptosis | CASP1 | caspase 1 | -0.19 | -0.03 | -2.69 | 0.49 | 0.99 | 22.7 | Detail |
| 405 | Huntington's Disease (HD) | apoptosis | DDIT4 | DNA damage inducible transcript 4 | 0.05 | 0.2 | 2.07 | 0.49 | 0.99 | 22.7 | Detail |
| 406 | Huntington's Disease (HD) | apoptosis | EYA2 | EYA transcriptional coactivator and phosphatase 2 | -0.19 | 0.08 | -1.17 | 0.49 | 0.99 | 22.7 | Detail |
| 407 | Huntington's Disease (HD) | apoptosis | TNFRSF10C | TNF receptor superfamily member 10c | -0.01 | 0.05 | 1.73 | 0.49 | 0.99 | 22.37 | Detail |
| 408 | Huntington's Disease (HD) | apoptosis | PSMC1 | proteasome 26S subunit, ATPase 1 | -0.13 | -0.01 | -3.55 | 0.49 | 0.99 | 22.37 | Detail |
| 409 | Huntington's Disease (HD) | apoptosis | ITGB1 | integrin subunit beta 1 | 0.01 | -0.06 | 1.89 | 0.49 | 0.99 | 22.37 | Detail |
| 410 | Huntington's Disease (HD) | apoptosis | MAL | mal, T cell differentiation protein | 0.25 | 0.06 | -2.05 | 0.49 | 0.99 | 22.37 | Detail |
| 411 | Huntington's Disease (HD) | apoptosis | PDCD5 | programmed cell death 5 | -0.15 | 0.07 | -1.13 | 0.49 | 0.99 | 22.37 | Detail |
| 412 | Huntington's Disease (HD) | apoptosis | RAC1 | Rac family small GTPase 1 | 0.12 | -0.13 | 0.13 | 0.5 | 0.99 | 22.04 | Detail |
| 413 | Huntington's Disease (HD) | apoptosis | INHBB | inhibin subunit beta B | -0.05 | 0.07 | 0.45 | 0.5 | 0.99 | 22.04 | Detail |
| 414 | Huntington's Disease (HD) | apoptosis | BAK1 | BCL2 antagonist/killer 1 | 0.15 | -0.02 | -3.02 | 0.5 | 0.99 | 22.04 | Detail |
| 415 | Huntington's Disease (HD) | apoptosis | TOPORS | TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase | -0.17 | 0.02 | -2.85 | 0.5 | 0.99 | 22.04 | Detail |
| 416 | Huntington's Disease (HD) | apoptosis | FASN | fatty acid synthase | 0.23 | 0.04 | -2.38 | 0.51 | 0.99 | 21.71 | Detail |
| 417 | Huntington's Disease (HD) | apoptosis | MADD | MAP kinase activating death domain | 0.12 | -0.04 | -1.74 | 0.51 | 0.99 | 21.71 | Detail |
| 418 | Huntington's Disease (HD) | apoptosis | FST | follistatin | 0.14 | 0.13 | -0.16 | 0.51 | 0.99 | 21.71 | Detail |
| 419 | Huntington's Disease (HD) | apoptosis | MAPK12 | mitogen-activated protein kinase 12 | 0.19 | 0.02 | -2.98 | 0.51 | 0.99 | 21.71 | Detail |
| 420 | Huntington's Disease (HD) | apoptosis | SGPL1 | sphingosine-1-phosphate lyase 1 | -0.09 | 0.1 | 0.21 | 0.51 | 0.99 | 21.71 | Detail |
| 421 | Huntington's Disease (HD) | apoptosis | ID2 | inhibitor of DNA binding 2 | 0.18 | -0.02 | -3.41 | 0.51 | 0.99 | 21.38 | Detail |
| 422 | Huntington's Disease (HD) | apoptosis | CD74 | CD74 molecule | -0.22 | -0.06 | -1.94 | 0.51 | 0.99 | 21.38 | Detail |
| 423 | Huntington's Disease (HD) | apoptosis | DDX3X | DEAD-box helicase 3 X-linked | -0.07 | 0.08 | 0.23 | 0.51 | 0.99 | 21.38 | Detail |
| 424 | Huntington's Disease (HD) | apoptosis | DDX5 | DEAD-box helicase 5 | -0.11 | 0.01 | -3.15 | 0.51 | 0.99 | 21.38 | Detail |
| 425 | Huntington's Disease (HD) | apoptosis | POLB | DNA polymerase beta | -0.1 | -0.14 | 0.48 | 0.51 | 0.99 | 21.38 | Detail |
| 426 | Huntington's Disease (HD) | apoptosis | PTEN | phosphatase and tensin homolog | -0.07 | 0.02 | -1.45 | 0.51 | 0.99 | 21.38 | Detail |
| 427 | Huntington's Disease (HD) | apoptosis | TRAP1 | TNF receptor associated protein 1 | -0.11 | 0.06 | -0.92 | 0.51 | 0.99 | 21.38 | Detail |
| 428 | Huntington's Disease (HD) | apoptosis | PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | -0.03 | -0.15 | 2.18 | 0.52 | 0.99 | 21.05 | Detail |
| 429 | Huntington's Disease (HD) | apoptosis | LSR | lipolysis stimulated lipoprotein receptor | -0.1 | 0.1 | 0.03 | 0.52 | 0.99 | 21.05 | Detail |
| 430 | Huntington's Disease (HD) | apoptosis | ETFA | electron transfer flavoprotein subunit alpha | 0.02 | -0.21 | 3.78 | 0.52 | 0.99 | 21.05 | Detail |
| 431 | Huntington's Disease (HD) | apoptosis | SFPQ | splicing factor proline and glutamine rich | -0.23 | 0.03 | -2.92 | 0.52 | 0.99 | 21.05 | Detail |
| 432 | Huntington's Disease (HD) | apoptosis | PSMB8 | proteasome 20S subunit beta 8 | -0.1 | 0.05 | -0.95 | 0.52 | 0.99 | 20.72 | Detail |
| 433 | Huntington's Disease (HD) | apoptosis | PITX2 | paired like homeodomain 2 | 0.04 | -0.09 | 1.22 | 0.52 | 0.99 | 20.72 | Detail |
| 434 | Huntington's Disease (HD) | apoptosis | ARMC10 | armadillo repeat containing 10 | 0.13 | -0.08 | -0.78 | 0.52 | 0.99 | 20.72 | Detail |
| 435 | Huntington's Disease (HD) | apoptosis | TMC8 | transmembrane channel like 8 | 0.25 | -0.01 | -4.85 | 0.52 | 0.99 | 20.72 | Detail |
| 436 | Huntington's Disease (HD) | apoptosis | NANOS3 | nanos C2HC-type zinc finger 3 | 0.28 | 0.07 | -1.97 | 0.53 | 0.99 | 20.39 | Detail |
| 437 | Huntington's Disease (HD) | apoptosis | PPP3CB | protein phosphatase 3 catalytic subunit beta | 0.14 | -0.1 | -0.55 | 0.53 | 0.99 | 20.39 | Detail |
| 438 | Huntington's Disease (HD) | apoptosis | EYA3 | EYA transcriptional coactivator and phosphatase 3 | 0.08 | -0.09 | 0.17 | 0.53 | 0.99 | 20.39 | Detail |
| 439 | Huntington's Disease (HD) | apoptosis | EYA4 | EYA transcriptional coactivator and phosphatase 4 | 0.03 | -0.08 | 1.28 | 0.53 | 0.99 | 20.39 | Detail |
| 440 | Huntington's Disease (HD) | apoptosis | FEM1B | fem-1 homolog B | 0.05 | -0.09 | 0.91 | 0.53 | 0.99 | 20.39 | Detail |
| 441 | Huntington's Disease (HD) | apoptosis | GNAI2 | G protein subunit alpha i2 | 0.14 | -0.03 | -2.06 | 0.53 | 0.99 | 20.39 | Detail |
| 442 | Huntington's Disease (HD) | apoptosis | GSK3B | glycogen synthase kinase 3 beta | -0.12 | -0.01 | -3.49 | 0.53 | 0.99 | 20.39 | Detail |
| 443 | Huntington's Disease (HD) | apoptosis | ZNF385A | zinc finger protein 385A | 0.09 | -0.12 | 0.34 | 0.53 | 0.99 | 20.39 | Detail |
| 444 | Huntington's Disease (HD) | apoptosis | PLA2G12B | phospholipase A2 group XIIB | 0.14 | 0.04 | -1.65 | 0.54 | 0.99 | 20.07 | Detail |
| 445 | Huntington's Disease (HD) | apoptosis | TLE1 | TLE family member 1, transcriptional corepressor | -0.1 | 0.03 | -1.66 | 0.54 | 0.99 | 20.07 | Detail |
| 446 | Huntington's Disease (HD) | apoptosis | IFI27L1 | interferon alpha inducible protein 27 like 1 | 0.25 | 0.08 | -1.74 | 0.54 | 0.99 | 20.07 | Detail |
| 447 | Huntington's Disease (HD) | apoptosis | TMEM14A | transmembrane protein 14A | 0.08 | -0.08 | 0.1 | 0.54 | 0.99 | 20.07 | Detail |
| 448 | Huntington's Disease (HD) | apoptosis | PSMD7 | proteasome 26S subunit, non-ATPase 7 | 0.02 | -0.17 | 3.46 | 0.55 | 0.99 | 19.74 | Detail |
| 449 | Huntington's Disease (HD) | apoptosis | DBH | dopamine beta-hydroxylase | 0.05 | 0.02 | -1.67 | 0.55 | 0.99 | 19.74 | Detail |
| 450 | Huntington's Disease (HD) | apoptosis | BCL2L11 | BCL2 like 11 | -0.09 | 0.08 | -0.22 | 0.55 | 0.99 | 19.74 | Detail |
| 451 | Huntington's Disease (HD) | apoptosis | PRF1 | perforin 1 | 0.12 | 0.04 | -1.72 | 0.55 | 0.99 | 19.41 | Detail |
| 452 | Huntington's Disease (HD) | apoptosis | PSMA8 | proteasome 20S subunit alpha 8 | 0.05 | -0.13 | 1.43 | 0.55 | 0.99 | 19.41 | Detail |
| 453 | Huntington's Disease (HD) | apoptosis | POMP | proteasome maturation protein | 0.13 | -0.13 | -0.1 | 0.55 | 0.99 | 19.41 | Detail |
| 454 | Huntington's Disease (HD) | apoptosis | PRKACG | protein kinase cAMP-activated catalytic subunit gamma | -0.1 | 0.05 | -0.98 | 0.55 | 0.99 | 19.41 | Detail |
| 455 | Huntington's Disease (HD) | apoptosis | NDUFS3 | NADH:ubiquinone oxidoreductase core subunit S3 | -0.03 | 0.05 | 0.76 | 0.55 | 0.99 | 19.41 | Detail |
| 456 | Huntington's Disease (HD) | apoptosis | NOS3 | nitric oxide synthase 3 | 0.02 | 0.17 | 3.4 | 0.56 | 0.99 | 19.08 | Detail |
| 457 | Huntington's Disease (HD) | apoptosis | PTGS2 | prostaglandin-endoperoxide synthase 2 | -0.18 | -0.03 | -2.62 | 0.56 | 0.99 | 19.08 | Detail |
| 458 | Huntington's Disease (HD) | apoptosis | BIK | BCL2 interacting killer | -0.12 | 0.0 | -4.68 | 0.56 | 0.99 | 19.08 | Detail |
| 459 | Huntington's Disease (HD) | apoptosis | FGB | fibrinogen beta chain | -0.1 | 0.01 | -2.9 | 0.56 | 0.99 | 19.08 | Detail |
| 460 | Huntington's Disease (HD) | apoptosis | CFL2 | cofilin 2 | -0.09 | -0.05 | -0.93 | 0.57 | 0.99 | 18.75 | Detail |
| 461 | Huntington's Disease (HD) | apoptosis | GAS2 | growth arrest specific 2 | -0.17 | 0.05 | -1.76 | 0.57 | 0.99 | 18.75 | Detail |
| 462 | Huntington's Disease (HD) | apoptosis | SHC2 | SHC adaptor protein 2 | 0.05 | -0.01 | -2.13 | 0.57 | 0.99 | 18.75 | Detail |
| 463 | Huntington's Disease (HD) | apoptosis | PSME4 | proteasome activator subunit 4 | 0.15 | -0.02 | -3.08 | 0.57 | 0.99 | 18.75 | Detail |
| 464 | Huntington's Disease (HD) | apoptosis | ZNF205 | zinc finger protein 205 | 0.16 | 0.09 | -0.87 | 0.57 | 0.99 | 18.75 | Detail |
| 465 | Huntington's Disease (HD) | apoptosis | NFKBIA | NFKB inhibitor alpha | 0.16 | 0.03 | -2.4 | 0.57 | 0.99 | 18.42 | Detail |
| 466 | Huntington's Disease (HD) | apoptosis | PRKACB | protein kinase cAMP-activated catalytic subunit beta | -0.02 | 0.02 | 0.24 | 0.57 | 0.99 | 18.42 | Detail |
| 467 | Huntington's Disease (HD) | apoptosis | CDIP1 | cell death inducing p53 target 1 | 0.17 | -0.03 | -2.54 | 0.57 | 0.99 | 18.42 | Detail |
| 468 | Huntington's Disease (HD) | apoptosis | DIDO1 | death inducer-obliterator 1 | -0.2 | 0.01 | -4.16 | 0.57 | 0.99 | 18.42 | Detail |
| 469 | Huntington's Disease (HD) | apoptosis | NBN | nibrin | -0.21 | -0.01 | -3.95 | 0.57 | 0.99 | 18.42 | Detail |
| 470 | Huntington's Disease (HD) | apoptosis | NFATC2 | nuclear factor of activated T cells 2 | -0.06 | 0.08 | 0.43 | 0.58 | 0.99 | 18.09 | Detail |
| 471 | Huntington's Disease (HD) | apoptosis | PPP3R2 | protein phosphatase 3 regulatory subunit B, beta | 0.12 | 0.04 | -1.54 | 0.58 | 0.99 | 18.09 | Detail |
| 472 | Huntington's Disease (HD) | apoptosis | SGPP1 | sphingosine-1-phosphate phosphatase 1 | 0.01 | -0.1 | 3.52 | 0.58 | 0.99 | 18.09 | Detail |
| 473 | Huntington's Disease (HD) | apoptosis | UMOD | uromodulin | -0.05 | 0.15 | 1.63 | 0.58 | 0.99 | 18.09 | Detail |
| 474 | Huntington's Disease (HD) | apoptosis | KRT18 | keratin 18 | -0.05 | 0.14 | 1.48 | 0.59 | 0.99 | 17.76 | Detail |
| 475 | Huntington's Disease (HD) | apoptosis | TGFBR2 | transforming growth factor beta receptor 2 | -0.07 | 0.06 | -0.03 | 0.59 | 0.99 | 17.76 | Detail |
| 476 | Huntington's Disease (HD) | apoptosis | PSMC3 | proteasome 26S subunit, ATPase 3 | -0.07 | 0.02 | -1.55 | 0.59 | 0.99 | 17.76 | Detail |
| 477 | Huntington's Disease (HD) | apoptosis | TRIM32 | tripartite motif containing 32 | -0.05 | 0.14 | 1.58 | 0.59 | 0.99 | 17.76 | Detail |
| 478 | Huntington's Disease (HD) | apoptosis | BAG5 | BAG cochaperone 5 | 0.08 | -0.11 | 0.51 | 0.59 | 0.99 | 17.76 | Detail |
| 479 | Huntington's Disease (HD) | apoptosis | KDR | kinase insert domain receptor | -0.23 | -0.02 | -3.27 | 0.59 | 0.99 | 17.43 | Detail |
| 480 | Huntington's Disease (HD) | apoptosis | BTK | Bruton tyrosine kinase | -0.19 | -0.13 | -0.57 | 0.59 | 0.99 | 17.43 | Detail |
| 481 | Huntington's Disease (HD) | apoptosis | IKBKE | inhibitor of nuclear factor kappa B kinase subunit epsilon | 0.02 | 0.07 | 2.27 | 0.59 | 0.99 | 17.43 | Detail |
| 482 | Huntington's Disease (HD) | apoptosis | NCK1 | NCK adaptor protein 1 | -0.12 | -0.1 | -0.33 | 0.59 | 0.99 | 17.43 | Detail |
| 483 | Huntington's Disease (HD) | apoptosis | PDCD6 | programmed cell death 6 | 0.02 | 0.1 | 2.61 | 0.59 | 0.99 | 17.43 | Detail |
| 484 | Huntington's Disease (HD) | apoptosis | URI1 | URI1 prefoldin like chaperone | -0.07 | 0.07 | 0.06 | 0.59 | 0.99 | 17.43 | Detail |
| 485 | Huntington's Disease (HD) | apoptosis | PIDD1 | p53-induced death domain protein 1 | 0.13 | 0.04 | -1.75 | 0.59 | 0.99 | 17.43 | Detail |
| 486 | Huntington's Disease (HD) | apoptosis | ATP2B4 | ATPase plasma membrane Ca2+ transporting 4 | 0.01 | 0.0 | -0.81 | 0.59 | 0.99 | 17.43 | Detail |
| 487 | Huntington's Disease (HD) | apoptosis | PLA1A | phospholipase A1 member A | 0.02 | -0.11 | 2.43 | 0.6 | 0.99 | 17.11 | Detail |
| 488 | Huntington's Disease (HD) | apoptosis | CAV1 | caveolin 1 | 0.17 | 0.01 | -3.71 | 0.6 | 0.99 | 17.11 | Detail |
| 489 | Huntington's Disease (HD) | apoptosis | BAG3 | BAG cochaperone 3 | 0.18 | 0.05 | -1.96 | 0.6 | 0.99 | 17.11 | Detail |
| 490 | Huntington's Disease (HD) | apoptosis | RET | ret proto-oncogene | 0.11 | -0.07 | -0.68 | 0.6 | 0.99 | 17.11 | Detail |
| 491 | Huntington's Disease (HD) | apoptosis | YAP1 | Yes1 associated transcriptional regulator | -0.01 | -0.14 | 3.63 | 0.6 | 0.99 | 17.11 | Detail |
| 492 | Huntington's Disease (HD) | apoptosis | MAPK3 | mitogen-activated protein kinase 3 | -0.04 | 0.03 | -0.37 | 0.61 | 0.99 | 16.78 | Detail |
| 493 | Huntington's Disease (HD) | apoptosis | IL1RAP | interleukin 1 receptor accessory protein | -0.03 | -0.07 | 1.22 | 0.61 | 0.99 | 16.78 | Detail |
| 494 | Huntington's Disease (HD) | apoptosis | CASP10 | caspase 10 | -0.06 | 0.07 | 0.12 | 0.61 | 0.99 | 16.78 | Detail |
| 495 | Huntington's Disease (HD) | apoptosis | ACAA2 | acetyl-CoA acyltransferase 2 | 0.01 | 0.13 | 3.26 | 0.61 | 0.99 | 16.78 | Detail |
| 496 | Huntington's Disease (HD) | apoptosis | CEBPB | CCAAT enhancer binding protein beta | -0.0 | 0.01 | 2.61 | 0.61 | 0.99 | 16.78 | Detail |
| 497 | Huntington's Disease (HD) | apoptosis | PTH | parathyroid hormone | 0.13 | -0.01 | -3.37 | 0.61 | 0.99 | 16.78 | Detail |
| 498 | Huntington's Disease (HD) | apoptosis | SLFN12 | schlafen family member 12 | 0.02 | -0.16 | 3.34 | 0.61 | 0.99 | 16.78 | Detail |
| 499 | Huntington's Disease (HD) | apoptosis | AMHR2 | anti-Mullerian hormone receptor type 2 | 0.18 | 0.07 | -1.44 | 0.61 | 0.99 | 16.61 | Detail |
| 500 | Huntington's Disease (HD) | apoptosis | CCK | cholecystokinin | 0.03 | 0.02 | -0.33 | 0.61 | 0.99 | 16.61 | Detail |
| 501 | Huntington's Disease (HD) | apoptosis | BAD | BCL2 associated agonist of cell death | -0.1 | 0.02 | -2.39 | 0.61 | 0.99 | 16.45 | Detail |
| 502 | Huntington's Disease (HD) | apoptosis | BCL2 | BCL2 apoptosis regulator | -0.04 | 0.03 | -0.21 | 0.62 | 0.99 | 16.12 | Detail |
| 503 | Huntington's Disease (HD) | apoptosis | GZMB | granzyme B | -0.01 | 0.16 | 3.62 | 0.62 | 0.99 | 16.12 | Detail |
| 504 | Huntington's Disease (HD) | apoptosis | CREBBP | CREB binding protein | -0.04 | 0.02 | -0.61 | 0.62 | 0.99 | 16.12 | Detail |
| 505 | Huntington's Disease (HD) | apoptosis | FAIM2 | Fas apoptotic inhibitory molecule 2 | 0.11 | 0.03 | -2.11 | 0.62 | 0.99 | 16.12 | Detail |
| 506 | Huntington's Disease (HD) | apoptosis | ITM2C | integral membrane protein 2C | -0.0 | -0.0 | -0.96 | 0.62 | 0.99 | 16.12 | Detail |
| 507 | Huntington's Disease (HD) | apoptosis | PARP2 | poly(ADP-ribose) polymerase 2 | -0.02 | -0.03 | 0.92 | 0.62 | 0.99 | 16.12 | Detail |
| 508 | Huntington's Disease (HD) | apoptosis | PERP | p53 apoptosis effector related to PMP22 | 0.01 | -0.06 | 2.1 | 0.62 | 0.99 | 16.12 | Detail |
| 509 | Huntington's Disease (HD) | apoptosis | TCF7L2 | transcription factor 7 like 2 | -0.0 | -0.14 | 5.25 | 0.62 | 0.99 | 16.12 | Detail |
| 510 | Huntington's Disease (HD) | apoptosis | ZDHHC3 | zinc finger DHHC-type palmitoyltransferase 3 | 0.16 | -0.04 | -2.05 | 0.62 | 0.99 | 16.12 | Detail |
| 511 | Huntington's Disease (HD) | apoptosis | CHUK | component of inhibitor of nuclear factor kappa B kinase complex | 0.06 | -0.08 | 0.43 | 0.63 | 0.99 | 15.79 | Detail |
| 512 | Huntington's Disease (HD) | apoptosis | CYCS | cytochrome c, somatic | 0.11 | 0.02 | -2.69 | 0.63 | 0.99 | 15.79 | Detail |
| 513 | Huntington's Disease (HD) | apoptosis | CAPN1 | calpain 1 | 0.15 | -0.01 | -3.71 | 0.63 | 0.99 | 15.79 | Detail |
| 514 | Huntington's Disease (HD) | apoptosis | TANK | TRAF family member associated NFKB activator | 0.0 | -0.07 | 4.3 | 0.63 | 0.99 | 15.79 | Detail |
| 515 | Huntington's Disease (HD) | apoptosis | PLA2G3 | phospholipase A2 group III | 0.13 | 0.04 | -1.78 | 0.63 | 0.99 | 15.79 | Detail |
| 516 | Huntington's Disease (HD) | apoptosis | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | 0.02 | -0.09 | 2.46 | 0.63 | 0.99 | 15.79 | Detail |
| 517 | Huntington's Disease (HD) | apoptosis | BCL2L12 | BCL2 like 12 | 0.06 | -0.04 | -0.89 | 0.63 | 0.99 | 15.79 | Detail |
| 518 | Huntington's Disease (HD) | apoptosis | PSMD10 | proteasome 26S subunit, non-ATPase 10 | 0.03 | -0.12 | 2.06 | 0.63 | 0.99 | 15.79 | Detail |
| 519 | Huntington's Disease (HD) | apoptosis | PLA2G2F | phospholipase A2 group IIF | -0.08 | 0.09 | 0.1 | 0.64 | 0.99 | 15.46 | Detail |
| 520 | Huntington's Disease (HD) | apoptosis | DAXX | death domain associated protein | 0.09 | 0.0 | -4.84 | 0.64 | 0.99 | 15.46 | Detail |
| 521 | Huntington's Disease (HD) | apoptosis | PDK1 | pyruvate dehydrogenase kinase 1 | -0.15 | 0.01 | -3.52 | 0.64 | 0.99 | 15.46 | Detail |
| 522 | Huntington's Disease (HD) | apoptosis | TRAF7 | TNF receptor associated factor 7 | 0.14 | 0.0 | -5.27 | 0.64 | 0.99 | 15.46 | Detail |
| 523 | Huntington's Disease (HD) | apoptosis | AEN | apoptosis enhancing nuclease | 0.11 | 0.11 | -0.06 | 0.64 | 0.99 | 15.3 | Detail |
| 524 | Huntington's Disease (HD) | apoptosis | THBS4 | thrombospondin 4 | 0.08 | -0.04 | -1.17 | 0.64 | 0.99 | 15.13 | Detail |
| 525 | Huntington's Disease (HD) | apoptosis | PSMA2 | proteasome 20S subunit alpha 2 | -0.02 | 0.01 | -1.09 | 0.64 | 0.99 | 15.13 | Detail |
| 526 | Huntington's Disease (HD) | apoptosis | GLRX2 | glutaredoxin 2 | -0.05 | 0.01 | -3.04 | 0.64 | 0.99 | 15.13 | Detail |
| 527 | Huntington's Disease (HD) | apoptosis | IFI27L2 | interferon alpha inducible protein 27 like 2 | 0.1 | 0.0 | -4.7 | 0.64 | 0.99 | 15.13 | Detail |
| 528 | Huntington's Disease (HD) | apoptosis | PDCD10 | programmed cell death 10 | 0.14 | 0.0 | -5.76 | 0.64 | 0.99 | 15.13 | Detail |
| 529 | Huntington's Disease (HD) | apoptosis | PTTG1IP | PTTG1 interacting protein | 0.13 | -0.12 | -0.12 | 0.64 | 0.99 | 15.13 | Detail |
| 530 | Huntington's Disease (HD) | apoptosis | CASP6 | caspase 6 | -0.07 | 0.14 | 1.04 | 0.65 | 0.99 | 14.8 | Detail |
| 531 | Huntington's Disease (HD) | apoptosis | BIRC3 | baculoviral IAP repeat containing 3 | -0.05 | 0.0 | -3.47 | 0.65 | 0.99 | 14.8 | Detail |
| 532 | Huntington's Disease (HD) | apoptosis | MCL1 | MCL1 apoptosis regulator, BCL2 family member | 0.11 | -0.08 | -0.37 | 0.65 | 0.99 | 14.8 | Detail |
| 533 | Huntington's Disease (HD) | apoptosis | STK25 | serine/threonine kinase 25 | -0.07 | 0.05 | -0.52 | 0.65 | 0.99 | 14.8 | Detail |
| 534 | Huntington's Disease (HD) | apoptosis | PLCG1 | phospholipase C gamma 1 | 0.09 | 0.19 | 1.1 | 0.66 | 0.99 | 14.47 | Detail |
| 535 | Huntington's Disease (HD) | apoptosis | FAF1 | Fas associated factor 1 | -0.09 | -0.02 | -2.49 | 0.66 | 0.99 | 14.47 | Detail |
| 536 | Huntington's Disease (HD) | apoptosis | HIP1 | huntingtin interacting protein 1 | 0.03 | 0.02 | -0.66 | 0.66 | 0.99 | 14.47 | Detail |
| 537 | Huntington's Disease (HD) | apoptosis | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 0.05 | 0.14 | 1.41 | 0.66 | 0.99 | 14.47 | Detail |
| 538 | Huntington's Disease (HD) | apoptosis | NOL3 | nucleolar protein 3 | 0.02 | 0.08 | 1.88 | 0.66 | 0.99 | 14.47 | Detail |
| 539 | Huntington's Disease (HD) | apoptosis | MAPK1 | mitogen-activated protein kinase 1 | 0.07 | -0.08 | 0.24 | 0.66 | 0.99 | 14.47 | Detail |
| 540 | Huntington's Disease (HD) | apoptosis | CD24 | CD24 molecule | -0.05 | -0.12 | 1.23 | 0.66 | 0.99 | 14.47 | Detail |
| 541 | Huntington's Disease (HD) | apoptosis | CTH | cystathionine gamma-lyase | 0.01 | -0.03 | 1.74 | 0.66 | 0.99 | 14.47 | Detail |
| 542 | Huntington's Disease (HD) | apoptosis | APAF1 | apoptotic peptidase activating factor 1 | -0.08 | -0.06 | -0.3 | 0.67 | 0.99 | 14.14 | Detail |
| 543 | Huntington's Disease (HD) | apoptosis | PPP2CA | protein phosphatase 2 catalytic subunit alpha | -0.12 | -0.05 | -1.19 | 0.67 | 0.99 | 14.14 | Detail |
| 544 | Huntington's Disease (HD) | apoptosis | IL33 | interleukin 33 | 0.24 | 0.02 | -3.31 | 0.67 | 0.99 | 14.14 | Detail |
| 545 | Huntington's Disease (HD) | apoptosis | BMP8B | bone morphogenetic protein 8b | -0.15 | 0.01 | -3.59 | 0.67 | 0.99 | 13.82 | Detail |
| 546 | Huntington's Disease (HD) | apoptosis | CD244 | CD244 molecule | -0.02 | 0.04 | 1.35 | 0.67 | 0.99 | 13.82 | Detail |
| 547 | Huntington's Disease (HD) | apoptosis | S100A8 | S100 calcium binding protein A8 | -0.06 | 0.05 | -0.25 | 0.67 | 0.99 | 13.82 | Detail |
| 548 | Huntington's Disease (HD) | apoptosis | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | -0.01 | -0.01 | -0.26 | 0.67 | 0.99 | 13.82 | Detail |
| 549 | Huntington's Disease (HD) | apoptosis | GSN | gelsolin | 0.03 | -0.11 | 1.69 | 0.68 | 0.99 | 13.49 | Detail |
| 550 | Huntington's Disease (HD) | apoptosis | MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | -0.02 | -0.06 | 1.82 | 0.68 | 0.99 | 13.49 | Detail |
| 551 | Huntington's Disease (HD) | apoptosis | PRKACA | protein kinase cAMP-activated catalytic subunit alpha | 0.0 | -0.11 | 6.44 | 0.68 | 0.99 | 13.49 | Detail |
| 552 | Huntington's Disease (HD) | apoptosis | ARHGEF2 | Rho/Rac guanine nucleotide exchange factor 2 | 0.07 | -0.05 | -0.6 | 0.68 | 0.99 | 13.49 | Detail |
| 553 | Huntington's Disease (HD) | apoptosis | ATF3 | activating transcription factor 3 | 0.11 | 0.03 | -1.97 | 0.68 | 0.99 | 13.49 | Detail |
| 554 | Huntington's Disease (HD) | apoptosis | PLEKHF1 | pleckstrin homology and FYVE domain containing 1 | 0.16 | -0.0 | -5.6 | 0.68 | 0.99 | 13.49 | Detail |
| 555 | Huntington's Disease (HD) | apoptosis | INHBC | inhibin subunit beta C | -0.07 | 0.1 | 0.53 | 0.69 | 0.99 | 13.16 | Detail |
| 556 | Huntington's Disease (HD) | apoptosis | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 0.09 | 0.19 | 1.13 | 0.69 | 0.99 | 13.16 | Detail |
| 557 | Huntington's Disease (HD) | apoptosis | CX3CL1 | C-X3-C motif chemokine ligand 1 | 0.07 | 0.15 | 1.16 | 0.69 | 0.99 | 13.16 | Detail |
| 558 | Huntington's Disease (HD) | apoptosis | MAPK8 | mitogen-activated protein kinase 8 | -0.14 | -0.05 | -1.49 | 0.69 | 0.99 | 13.16 | Detail |
| 559 | Huntington's Disease (HD) | apoptosis | TOP2A | DNA topoisomerase II alpha | 0.05 | -0.02 | -1.39 | 0.7 | 0.99 | 12.83 | Detail |
| 560 | Huntington's Disease (HD) | apoptosis | LIMK1 | LIM domain kinase 1 | 0.01 | -0.1 | 4.11 | 0.7 | 0.99 | 12.83 | Detail |
| 561 | Huntington's Disease (HD) | apoptosis | NODAL | nodal growth differentiation factor | 0.04 | 0.11 | 1.54 | 0.7 | 0.99 | 12.83 | Detail |
| 562 | Huntington's Disease (HD) | apoptosis | SPTAN1 | spectrin alpha, non-erythrocytic 1 | 0.09 | 0.12 | 0.33 | 0.7 | 0.99 | 12.83 | Detail |
| 563 | Huntington's Disease (HD) | apoptosis | SAP18 | Sin3A associated protein 18 | -0.04 | 0.09 | 1.18 | 0.7 | 0.99 | 12.83 | Detail |
| 564 | Huntington's Disease (HD) | apoptosis | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 0.03 | -0.03 | 0.21 | 0.7 | 0.99 | 12.83 | Detail |
| 565 | Huntington's Disease (HD) | apoptosis | CDC42 | cell division cycle 42 | -0.1 | -0.06 | -0.76 | 0.7 | 0.99 | 12.5 | Detail |
| 566 | Huntington's Disease (HD) | apoptosis | PLA2G4A | phospholipase A2 group IVA | -0.09 | -0.06 | -0.63 | 0.7 | 0.99 | 12.5 | Detail |
| 567 | Huntington's Disease (HD) | apoptosis | PSMD11 | proteasome 26S subunit, non-ATPase 11 | -0.07 | 0.05 | -0.28 | 0.7 | 0.99 | 12.5 | Detail |
| 568 | Huntington's Disease (HD) | apoptosis | BDKRB2 | bradykinin receptor B2 | -0.1 | 0.07 | -0.51 | 0.7 | 0.99 | 12.5 | Detail |
| 569 | Huntington's Disease (HD) | apoptosis | ENO1 | enolase 1 | 0.06 | -0.01 | -2.26 | 0.7 | 0.99 | 12.5 | Detail |
| 570 | Huntington's Disease (HD) | apoptosis | IVNS1ABP | influenza virus NS1A binding protein | -0.13 | -0.0 | -4.91 | 0.7 | 0.99 | 12.5 | Detail |
| 571 | Huntington's Disease (HD) | apoptosis | PDPK1 | 3-phosphoinositide dependent protein kinase 1 | -0.08 | 0.01 | -2.74 | 0.7 | 0.99 | 12.5 | Detail |
| 572 | Huntington's Disease (HD) | apoptosis | IKBKB | inhibitor of nuclear factor kappa B kinase subunit beta | -0.05 | 0.07 | 0.57 | 0.71 | 0.99 | 12.17 | Detail |
| 573 | Huntington's Disease (HD) | apoptosis | NAB2 | NGFI-A binding protein 2 | -0.03 | 0.02 | -0.64 | 0.71 | 0.99 | 12.17 | Detail |
| 574 | Huntington's Disease (HD) | apoptosis | TRAF1 | TNF receptor associated factor 1 | -0.12 | 0.08 | -0.63 | 0.71 | 0.99 | 12.17 | Detail |
| 575 | Huntington's Disease (HD) | apoptosis | ZNF385B | zinc finger protein 385B | -0.11 | -0.02 | -2.68 | 0.71 | 0.99 | 12.17 | Detail |
| 576 | Huntington's Disease (HD) | apoptosis | LEFTY1 | left-right determination factor 1 | 0.12 | 0.06 | -1.05 | 0.72 | 0.99 | 11.84 | Detail |
| 577 | Huntington's Disease (HD) | apoptosis | IGF1 | insulin like growth factor 1 | 0.05 | 0.02 | -1.46 | 0.72 | 0.99 | 11.84 | Detail |
| 578 | Huntington's Disease (HD) | apoptosis | MDM2 | MDM2 proto-oncogene | -0.15 | -0.02 | -2.94 | 0.72 | 0.99 | 11.84 | Detail |
| 579 | Huntington's Disease (HD) | apoptosis | DAPL1 | death associated protein like 1 | 0.18 | 0.16 | -0.09 | 0.72 | 0.99 | 11.68 | Detail |
| 580 | Huntington's Disease (HD) | apoptosis | PLCG2 | phospholipase C gamma 2 | -0.1 | -0.01 | -3.85 | 0.73 | 0.99 | 11.51 | Detail |
| 581 | Huntington's Disease (HD) | apoptosis | CASP12 | caspase 12 (gene/pseudogene) | -0.13 | -0.03 | -2.13 | 0.73 | 0.99 | 11.51 | Detail |
| 582 | Huntington's Disease (HD) | apoptosis | SCN2A | sodium voltage-gated channel alpha subunit 2 | 0.04 | -0.1 | 1.35 | 0.73 | 0.99 | 11.51 | Detail |
| 583 | Huntington's Disease (HD) | apoptosis | SMAD2 | SMAD family member 2 | -0.04 | -0.07 | 0.72 | 0.73 | 0.99 | 11.18 | Detail |
| 584 | Huntington's Disease (HD) | apoptosis | PSMD3 | proteasome 26S subunit, non-ATPase 3 | -0.15 | 0.01 | -4.36 | 0.73 | 0.99 | 11.18 | Detail |
| 585 | Huntington's Disease (HD) | apoptosis | AGT | angiotensinogen | 0.16 | 0.08 | -0.98 | 0.73 | 0.99 | 11.18 | Detail |
| 586 | Huntington's Disease (HD) | apoptosis | CTNNA1 | catenin alpha 1 | 0.05 | -0.04 | -0.53 | 0.73 | 0.99 | 11.18 | Detail |
| 587 | Huntington's Disease (HD) | apoptosis | CTSH | cathepsin H | -0.14 | -0.08 | -0.8 | 0.73 | 0.99 | 11.18 | Detail |
| 588 | Huntington's Disease (HD) | apoptosis | FAM162A | family with sequence similarity 162 member A | -0.1 | -0.01 | -2.88 | 0.73 | 0.99 | 11.18 | Detail |
| 589 | Huntington's Disease (HD) | apoptosis | FNIP2 | folliculin interacting protein 2 | -0.03 | -0.07 | 1.3 | 0.73 | 0.99 | 11.18 | Detail |
| 590 | Huntington's Disease (HD) | apoptosis | HMOX1 | heme oxygenase 1 | -0.07 | -0.07 | 0.05 | 0.73 | 0.99 | 11.18 | Detail |
| 591 | Huntington's Disease (HD) | apoptosis | IL7 | interleukin 7 | -0.1 | 0.0 | -6.8 | 0.73 | 0.99 | 11.18 | Detail |
| 592 | Huntington's Disease (HD) | apoptosis | PLA2G6 | phospholipase A2 group VI | 0.14 | -0.01 | -4.76 | 0.74 | 0.99 | 10.86 | Detail |
| 593 | Huntington's Disease (HD) | apoptosis | EP300 | E1A binding protein p300 | -0.15 | 0.09 | -0.73 | 0.74 | 0.99 | 10.86 | Detail |
| 594 | Huntington's Disease (HD) | apoptosis | RBL1 | RB transcriptional corepressor like 1 | 0.03 | 0.03 | -0.14 | 0.74 | 0.99 | 10.86 | Detail |
| 595 | Huntington's Disease (HD) | apoptosis | CYP1B1 | cytochrome P450 family 1 subfamily B member 1 | 0.1 | -0.01 | -3.0 | 0.74 | 0.99 | 10.86 | Detail |
| 596 | Huntington's Disease (HD) | apoptosis | TICAM1 | TIR domain containing adaptor molecule 1 | 0.09 | -0.02 | -2.41 | 0.74 | 0.99 | 10.86 | Detail |
| 597 | Huntington's Disease (HD) | apoptosis | PLA2G2D | phospholipase A2 group IID | -0.08 | -0.01 | -3.76 | 0.75 | 0.99 | 10.53 | Detail |
| 598 | Huntington's Disease (HD) | apoptosis | HDAC1 | histone deacetylase 1 | 0.11 | -0.0 | -5.71 | 0.75 | 0.99 | 10.53 | Detail |
| 599 | Huntington's Disease (HD) | apoptosis | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.08 | -0.04 | -0.99 | 0.75 | 0.99 | 10.53 | Detail |
| 600 | Huntington's Disease (HD) | apoptosis | PPP1CA | protein phosphatase 1 catalytic subunit alpha | 0.07 | -0.03 | -1.36 | 0.75 | 0.99 | 10.53 | Detail |
| 601 | Huntington's Disease (HD) | apoptosis | DFFA | DNA fragmentation factor subunit alpha | 0.03 | -0.03 | -0.18 | 0.76 | 0.99 | 10.2 | Detail |
| 602 | Huntington's Disease (HD) | apoptosis | CD38 | CD38 molecule | -0.02 | -0.05 | 1.58 | 0.76 | 0.99 | 10.2 | Detail |
| 603 | Huntington's Disease (HD) | apoptosis | NOX1 | NADPH oxidase 1 | 0.17 | 0.15 | -0.16 | 0.76 | 0.99 | 10.2 | Detail |
| 604 | Huntington's Disease (HD) | apoptosis | PCF11 | PCF11 cleavage and polyadenylation factor subunit | -0.16 | -0.03 | -2.37 | 0.76 | 0.99 | 10.2 | Detail |
| 605 | Huntington's Disease (HD) | apoptosis | ATF4 | activating transcription factor 4 | -0.0 | 0.11 | 6.07 | 0.76 | 0.99 | 10.2 | Detail |
| 606 | Huntington's Disease (HD) | apoptosis | GSTP1 | glutathione S-transferase pi 1 | -0.1 | -0.04 | -1.3 | 0.76 | 0.99 | 10.2 | Detail |
| 607 | Huntington's Disease (HD) | apoptosis | LTBR | lymphotoxin beta receptor | 0.0 | 0.06 | 3.87 | 0.76 | 0.99 | 10.2 | Detail |
| 608 | Huntington's Disease (HD) | apoptosis | PAK2 | p21 (RAC1) activated kinase 2 | -0.11 | -0.06 | -0.88 | 0.76 | 0.99 | 10.2 | Detail |
| 609 | Huntington's Disease (HD) | apoptosis | NUMA1 | nuclear mitotic apparatus protein 1 | -0.06 | 0.1 | 0.79 | 0.76 | 0.99 | 9.87 | Detail |
| 610 | Huntington's Disease (HD) | apoptosis | PSMC6 | proteasome 26S subunit, ATPase 6 | 0.02 | -0.1 | 2.33 | 0.76 | 0.99 | 9.87 | Detail |
| 611 | Huntington's Disease (HD) | apoptosis | PPP1R13B | protein phosphatase 1 regulatory subunit 13B | 0.04 | 0.09 | 1.34 | 0.76 | 0.99 | 9.87 | Detail |
| 612 | Huntington's Disease (HD) | apoptosis | RPS7 | ribosomal protein S7 | 0.02 | 0.1 | 2.48 | 0.76 | 0.99 | 9.87 | Detail |
| 613 | Huntington's Disease (HD) | apoptosis | TNFRSF25 | TNF receptor superfamily member 25 | 0.14 | 0.05 | -1.44 | 0.76 | 0.99 | 9.87 | Detail |
| 614 | Huntington's Disease (HD) | apoptosis | TNFSF10 | TNF superfamily member 10 | 0.02 | -0.02 | -0.31 | 0.77 | 0.99 | 9.54 | Detail |
| 615 | Huntington's Disease (HD) | apoptosis | ROCK1 | Rho associated coiled-coil containing protein kinase 1 | -0.05 | 0.0 | -4.22 | 0.77 | 0.99 | 9.54 | Detail |
| 616 | Huntington's Disease (HD) | apoptosis | PPP3CA | protein phosphatase 3 catalytic subunit alpha | -0.08 | -0.05 | -0.67 | 0.77 | 0.99 | 9.54 | Detail |
| 617 | Huntington's Disease (HD) | apoptosis | ACVR1B | activin A receptor type 1B | -0.12 | -0.08 | -0.65 | 0.77 | 0.99 | 9.54 | Detail |
| 618 | Huntington's Disease (HD) | apoptosis | IL6R | interleukin 6 receptor | -0.0 | 0.0 | -0.02 | 0.77 | 0.99 | 9.54 | Detail |
| 619 | Huntington's Disease (HD) | apoptosis | PHIP | pleckstrin homology domain interacting protein | 0.01 | -0.02 | 0.85 | 0.77 | 0.99 | 9.54 | Detail |
| 620 | Huntington's Disease (HD) | apoptosis | USP47 | ubiquitin specific peptidase 47 | -0.1 | -0.01 | -3.73 | 0.77 | 0.99 | 9.54 | Detail |
| 621 | Huntington's Disease (HD) | apoptosis | PSMA5 | proteasome 20S subunit alpha 5 | -0.05 | 0.06 | 0.2 | 0.78 | 0.99 | 9.21 | Detail |
| 622 | Huntington's Disease (HD) | apoptosis | EXOG | exo/endonuclease G | 0.1 | 0.09 | -0.07 | 0.78 | 0.99 | 9.21 | Detail |
| 623 | Huntington's Disease (HD) | apoptosis | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | -0.01 | 0.03 | 1.34 | 0.78 | 0.99 | 9.21 | Detail |
| 624 | Huntington's Disease (HD) | apoptosis | SIAH1 | siah E3 ubiquitin protein ligase 1 | -0.07 | -0.08 | 0.15 | 0.78 | 0.99 | 9.21 | Detail |
| 625 | Huntington's Disease (HD) | apoptosis | STX4 | syntaxin 4 | 0.03 | -0.01 | -1.75 | 0.78 | 0.99 | 9.21 | Detail |
| 626 | Huntington's Disease (HD) | apoptosis | MYC | MYC proto-oncogene, bHLH transcription factor | -0.08 | 0.02 | -1.94 | 0.79 | 0.99 | 8.88 | Detail |
| 627 | Huntington's Disease (HD) | apoptosis | PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | -0.01 | 0.08 | 3.8 | 0.79 | 0.99 | 8.88 | Detail |
| 628 | Huntington's Disease (HD) | apoptosis | XIAP | X-linked inhibitor of apoptosis | -0.02 | -0.05 | 1.57 | 0.79 | 0.99 | 8.88 | Detail |
| 629 | Huntington's Disease (HD) | apoptosis | IRAK2 | interleukin 1 receptor associated kinase 2 | -0.03 | 0.02 | -0.77 | 0.79 | 0.99 | 8.88 | Detail |
| 630 | Huntington's Disease (HD) | apoptosis | GPER1 | G protein-coupled estrogen receptor 1 | 0.01 | -0.04 | 1.98 | 0.79 | 0.99 | 8.88 | Detail |
| 631 | Huntington's Disease (HD) | apoptosis | RPS27L | ribosomal protein S27 like | 0.04 | 0.06 | 0.64 | 0.79 | 0.99 | 8.88 | Detail |
| 632 | Huntington's Disease (HD) | apoptosis | TMEM161A | transmembrane protein 161A | 0.13 | 0.05 | -1.34 | 0.79 | 0.99 | 8.88 | Detail |
| 633 | Huntington's Disease (HD) | apoptosis | BIRC2 | baculoviral IAP repeat containing 2 | 0.01 | -0.03 | 1.8 | 0.8 | 0.99 | 8.55 | Detail |
| 634 | Huntington's Disease (HD) | apoptosis | IRAK1 | interleukin 1 receptor associated kinase 1 | 0.06 | 0.08 | 0.35 | 0.8 | 0.99 | 8.55 | Detail |
| 635 | Huntington's Disease (HD) | apoptosis | ATP2B2 | ATPase plasma membrane Ca2+ transporting 2 | 0.06 | 0.03 | -1.25 | 0.8 | 0.99 | 8.55 | Detail |
| 636 | Huntington's Disease (HD) | apoptosis | DEDD | death effector domain containing | -0.03 | -0.04 | 0.54 | 0.8 | 0.99 | 8.55 | Detail |
| 637 | Huntington's Disease (HD) | apoptosis | CCL27 | C-C motif chemokine ligand 27 | 0.02 | 0.07 | 1.5 | 0.8 | 0.99 | 8.39 | Detail |
| 638 | Huntington's Disease (HD) | apoptosis | PLA2G2E | phospholipase A2 group IIE | 0.18 | 0.06 | -1.63 | 0.8 | 0.99 | 8.39 | Detail |
| 639 | Huntington's Disease (HD) | apoptosis | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 0.07 | 0.03 | -1.31 | 0.8 | 0.99 | 8.22 | Detail |
| 640 | Huntington's Disease (HD) | apoptosis | CDKN2B | cyclin dependent kinase inhibitor 2B | -0.06 | -0.04 | -0.66 | 0.8 | 0.99 | 8.22 | Detail |
| 641 | Huntington's Disease (HD) | apoptosis | TGFB3 | transforming growth factor beta 3 | -0.0 | 0.02 | 2.71 | 0.8 | 0.99 | 8.22 | Detail |
| 642 | Huntington's Disease (HD) | apoptosis | FLRT1 | fibronectin leucine rich transmembrane protein 1 | -0.06 | 0.0 | -3.75 | 0.8 | 0.99 | 8.22 | Detail |
| 643 | Huntington's Disease (HD) | apoptosis | MAP2K2 | mitogen-activated protein kinase kinase 2 | 0.11 | -0.0 | -4.61 | 0.8 | 0.99 | 8.22 | Detail |
| 644 | Huntington's Disease (HD) | apoptosis | DDIT3 | DNA damage inducible transcript 3 | 0.06 | -0.02 | -1.55 | 0.8 | 0.99 | 8.22 | Detail |
| 645 | Huntington's Disease (HD) | apoptosis | BMP7 | bone morphogenetic protein 7 | 0.17 | 0.1 | -0.74 | 0.81 | 0.99 | 7.89 | Detail |
| 646 | Huntington's Disease (HD) | apoptosis | PSMC5 | proteasome 26S subunit, ATPase 5 | 0.03 | 0.06 | 0.86 | 0.81 | 0.99 | 7.89 | Detail |
| 647 | Huntington's Disease (HD) | apoptosis | CEACAM5 | CEA cell adhesion molecule 5 | -0.02 | 0.01 | -0.28 | 0.81 | 0.99 | 7.89 | Detail |
| 648 | Huntington's Disease (HD) | apoptosis | FGFR1 | fibroblast growth factor receptor 1 | -0.08 | -0.02 | -2.28 | 0.81 | 0.99 | 7.89 | Detail |
| 649 | Huntington's Disease (HD) | apoptosis | TP63 | tumor protein p63 | 0.06 | 0.11 | 0.93 | 0.81 | 0.99 | 7.89 | Detail |
| 650 | Huntington's Disease (HD) | apoptosis | WFS1 | wolframin ER transmembrane glycoprotein | 0.2 | 0.05 | -2.15 | 0.81 | 0.99 | 7.89 | Detail |
| 651 | Huntington's Disease (HD) | apoptosis | TLR4 | toll like receptor 4 | -0.01 | -0.06 | 2.82 | 0.81 | 0.99 | 7.89 | Detail |
| 652 | Huntington's Disease (HD) | apoptosis | TFDP1 | transcription factor Dp-1 | 0.29 | 0.02 | -3.63 | 0.82 | 0.99 | 7.57 | Detail |
| 653 | Huntington's Disease (HD) | apoptosis | PPP2R1A | protein phosphatase 2 scaffold subunit Aalpha | 0.05 | -0.06 | 0.23 | 0.82 | 0.99 | 7.57 | Detail |
| 654 | Huntington's Disease (HD) | apoptosis | SUFU | SUFU negative regulator of hedgehog signaling | -0.16 | -0.14 | -0.12 | 0.82 | 0.99 | 7.57 | Detail |
| 655 | Huntington's Disease (HD) | apoptosis | DDIAS | DNA damage induced apoptosis suppressor | 0.01 | -0.06 | 2.51 | 0.82 | 0.99 | 7.57 | Detail |
| 656 | Huntington's Disease (HD) | apoptosis | MAPK9 | mitogen-activated protein kinase 9 | -0.11 | -0.06 | -0.87 | 0.82 | 0.99 | 7.57 | Detail |
| 657 | Huntington's Disease (HD) | apoptosis | RTKN2 | rhotekin 2 | -0.05 | 0.06 | 0.15 | 0.82 | 0.99 | 7.57 | Detail |
| 658 | Huntington's Disease (HD) | apoptosis | TGFBR1 | transforming growth factor beta receptor 1 | -0.09 | -0.11 | 0.34 | 0.83 | 0.99 | 7.24 | Detail |
| 659 | Huntington's Disease (HD) | apoptosis | ID1 | inhibitor of DNA binding 1 | 0.09 | 0.05 | -0.79 | 0.83 | 0.99 | 7.24 | Detail |
| 660 | Huntington's Disease (HD) | apoptosis | TSC2 | TSC complex subunit 2 | 0.07 | 0.05 | -0.59 | 0.83 | 0.99 | 7.24 | Detail |
| 661 | Huntington's Disease (HD) | apoptosis | BDNF | brain derived neurotrophic factor | 0.08 | 0.04 | -0.93 | 0.83 | 0.99 | 7.24 | Detail |
| 662 | Huntington's Disease (HD) | apoptosis | HINT1 | histidine triad nucleotide binding protein 1 | 0.1 | 0.04 | -1.36 | 0.83 | 0.99 | 7.24 | Detail |
| 663 | Huntington's Disease (HD) | apoptosis | MLH1 | mutL homolog 1 | 0.05 | -0.1 | 0.86 | 0.83 | 0.99 | 7.24 | Detail |
| 664 | Huntington's Disease (HD) | apoptosis | PTPRC | protein tyrosine phosphatase receptor type C | 0.01 | -0.05 | 2.63 | 0.83 | 0.99 | 7.24 | Detail |
| 665 | Huntington's Disease (HD) | apoptosis | SLC25A5 | solute carrier family 25 member 5 | 0.06 | 0.01 | -2.92 | 0.83 | 0.99 | 7.24 | Detail |
| 666 | Huntington's Disease (HD) | apoptosis | NCOA3 | nuclear receptor coactivator 3 | -0.16 | -0.04 | -2.08 | 0.83 | 0.99 | 7.24 | Detail |
| 667 | Huntington's Disease (HD) | apoptosis | SPHK2 | sphingosine kinase 2 | -0.01 | 0.02 | 0.25 | 0.83 | 0.99 | 7.24 | Detail |
| 668 | Huntington's Disease (HD) | apoptosis | ANXA6 | annexin A6 | 0.03 | 0.1 | 1.66 | 0.83 | 0.99 | 7.24 | Detail |
| 669 | Huntington's Disease (HD) | apoptosis | DAPK3 | death associated protein kinase 3 | 0.13 | 0.22 | 0.73 | 0.83 | 0.99 | 7.24 | Detail |
| 670 | Huntington's Disease (HD) | apoptosis | ITGA6 | integrin subunit alpha 6 | -0.11 | -0.03 | -1.99 | 0.83 | 0.99 | 7.24 | Detail |
| 671 | Huntington's Disease (HD) | apoptosis | SP1 | Sp1 transcription factor | -0.09 | -0.0 | -5.28 | 0.83 | 0.99 | 6.91 | Detail |
| 672 | Huntington's Disease (HD) | apoptosis | HRAS | HRas proto-oncogene, GTPase | 0.1 | 0.03 | -1.67 | 0.83 | 0.99 | 6.91 | Detail |
| 673 | Huntington's Disease (HD) | apoptosis | SMAD7 | SMAD family member 7 | 0.0 | -0.04 | 3.76 | 0.83 | 0.99 | 6.91 | Detail |
| 674 | Huntington's Disease (HD) | apoptosis | PRKX | protein kinase cAMP-dependent X-linked catalytic subunit | -0.07 | -0.04 | -0.65 | 0.83 | 0.99 | 6.91 | Detail |
| 675 | Huntington's Disease (HD) | apoptosis | NFATC4 | nuclear factor of activated T cells 4 | 0.14 | 0.04 | -1.76 | 0.83 | 0.99 | 6.91 | Detail |
| 676 | Huntington's Disease (HD) | apoptosis | CXCL12 | C-X-C motif chemokine ligand 12 | 0.2 | 0.02 | -3.13 | 0.83 | 0.99 | 6.91 | Detail |
| 677 | Huntington's Disease (HD) | apoptosis | SORT1 | sortilin 1 | -0.0 | -0.1 | 7.01 | 0.83 | 0.99 | 6.91 | Detail |
| 678 | Huntington's Disease (HD) | apoptosis | STK3 | serine/threonine kinase 3 | -0.03 | 0.02 | -0.92 | 0.83 | 0.99 | 6.91 | Detail |
| 679 | Huntington's Disease (HD) | apoptosis | TPD52L1 | TPD52 like 1 | 0.12 | 0.01 | -3.21 | 0.83 | 0.99 | 6.91 | Detail |
| 680 | Huntington's Disease (HD) | apoptosis | UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | -0.13 | -0.04 | -1.63 | 0.83 | 0.99 | 6.91 | Detail |
| 681 | Huntington's Disease (HD) | apoptosis | PTRH2 | peptidyl-tRNA hydrolase 2 | 0.07 | -0.0 | -3.85 | 0.84 | 0.99 | 6.58 | Detail |
| 682 | Huntington's Disease (HD) | apoptosis | HRK | harakiri, BCL2 interacting protein | -0.08 | -0.09 | 0.15 | 0.84 | 0.99 | 6.58 | Detail |
| 683 | Huntington's Disease (HD) | apoptosis | MAZ | MYC associated zinc finger protein | 0.06 | 0.02 | -1.44 | 0.84 | 0.99 | 6.58 | Detail |
| 684 | Huntington's Disease (HD) | apoptosis | RHOA | ras homolog family member A | -0.04 | -0.06 | 0.5 | 0.85 | 0.99 | 6.25 | Detail |
| 685 | Huntington's Disease (HD) | apoptosis | BMP8A | bone morphogenetic protein 8a | -0.1 | 0.08 | -0.38 | 0.85 | 0.99 | 6.25 | Detail |
| 686 | Huntington's Disease (HD) | apoptosis | ACVR1C | activin A receptor type 1C | 0.03 | -0.02 | -0.53 | 0.85 | 0.99 | 6.25 | Detail |
| 687 | Huntington's Disease (HD) | apoptosis | SMAD6 | SMAD family member 6 | 0.11 | 0.13 | 0.14 | 0.85 | 0.99 | 6.25 | Detail |
| 688 | Huntington's Disease (HD) | apoptosis | PELI3 | pellino E3 ubiquitin protein ligase family member 3 | -0.05 | -0.02 | -1.0 | 0.85 | 0.99 | 6.25 | Detail |
| 689 | Huntington's Disease (HD) | apoptosis | SIRT1 | sirtuin 1 | -0.04 | -0.03 | -0.33 | 0.85 | 0.99 | 6.25 | Detail |
| 690 | Huntington's Disease (HD) | apoptosis | APPL1 | adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | -0.13 | -0.05 | -1.45 | 0.85 | 0.99 | 6.25 | Detail |
| 691 | Huntington's Disease (HD) | apoptosis | NT5C3A | 5'-nucleotidase, cytosolic IIIA | -0.08 | -0.1 | 0.34 | 0.86 | 0.99 | 5.92 | Detail |
| 692 | Huntington's Disease (HD) | apoptosis | PSMC2 | proteasome 26S subunit, ATPase 2 | -0.07 | -0.01 | -3.0 | 0.86 | 0.99 | 5.92 | Detail |
| 693 | Huntington's Disease (HD) | apoptosis | BNIP3 | BCL2 interacting protein 3 | 0.02 | 0.03 | 0.78 | 0.86 | 0.99 | 5.92 | Detail |
| 694 | Huntington's Disease (HD) | apoptosis | DAP3 | death associated protein 3 | 0.02 | 0.12 | 2.51 | 0.86 | 0.99 | 5.92 | Detail |
| 695 | Huntington's Disease (HD) | apoptosis | NCK2 | NCK adaptor protein 2 | -0.07 | 0.05 | -0.4 | 0.86 | 0.99 | 5.92 | Detail |
| 696 | Huntington's Disease (HD) | apoptosis | OPA1 | OPA1 mitochondrial dynamin like GTPase | 0.0 | -0.04 | 6.8 | 0.86 | 0.99 | 5.92 | Detail |
| 697 | Huntington's Disease (HD) | apoptosis | PRKCD | protein kinase C delta | -0.05 | -0.02 | -1.24 | 0.86 | 0.99 | 5.92 | Detail |
| 698 | Huntington's Disease (HD) | apoptosis | RIPK3 | receptor interacting serine/threonine kinase 3 | -0.04 | 0.03 | -0.69 | 0.86 | 0.99 | 5.92 | Detail |
| 699 | Huntington's Disease (HD) | apoptosis | TFDP2 | transcription factor Dp-2 | -0.02 | 0.05 | 1.27 | 0.86 | 0.99 | 5.92 | Detail |
| 700 | Huntington's Disease (HD) | apoptosis | KRAS | KRAS proto-oncogene, GTPase | -0.03 | -0.08 | 1.35 | 0.87 | 0.99 | 5.59 | Detail |
| 701 | Huntington's Disease (HD) | apoptosis | VIM | vimentin | -0.02 | -0.12 | 2.41 | 0.87 | 0.99 | 5.59 | Detail |
| 702 | Huntington's Disease (HD) | apoptosis | HIPK2 | homeodomain interacting protein kinase 2 | 0.05 | -0.04 | -0.41 | 0.87 | 0.99 | 5.59 | Detail |
| 703 | Huntington's Disease (HD) | apoptosis | MMP9 | matrix metallopeptidase 9 | -0.12 | -0.02 | -2.55 | 0.87 | 0.99 | 5.59 | Detail |
| 704 | Huntington's Disease (HD) | apoptosis | PDE3A | phosphodiesterase 3A | -0.02 | -0.03 | 0.29 | 0.87 | 0.99 | 5.59 | Detail |
| 705 | Huntington's Disease (HD) | apoptosis | DCC | DCC netrin 1 receptor | 0.15 | -0.03 | -2.48 | 0.87 | 0.99 | 5.59 | Detail |
| 706 | Huntington's Disease (HD) | apoptosis | MAP2K1 | mitogen-activated protein kinase kinase 1 | -0.12 | -0.04 | -1.43 | 0.87 | 0.99 | 5.26 | Detail |
| 707 | Huntington's Disease (HD) | apoptosis | BRMS1 | BRMS1 transcriptional repressor and anoikis regulator | 0.05 | 0.02 | -1.11 | 0.87 | 0.99 | 5.26 | Detail |
| 708 | Huntington's Disease (HD) | apoptosis | CD28 | CD28 molecule | 0.01 | 0.01 | -0.53 | 0.87 | 0.99 | 5.26 | Detail |
| 709 | Huntington's Disease (HD) | apoptosis | LGALS3 | galectin 3 | -0.14 | -0.12 | -0.28 | 0.87 | 0.99 | 5.26 | Detail |
| 710 | Huntington's Disease (HD) | apoptosis | PRELID1 | PRELI domain containing 1 | -0.04 | -0.02 | -1.25 | 0.87 | 0.99 | 5.26 | Detail |
| 711 | Huntington's Disease (HD) | apoptosis | TFPT | TCF3 fusion partner | -0.0 | -0.05 | 5.84 | 0.87 | 0.99 | 5.26 | Detail |
| 712 | Huntington's Disease (HD) | apoptosis | PSMB5 | proteasome 20S subunit beta 5 | -0.02 | 0.12 | 2.63 | 0.87 | 0.99 | 5.26 | Detail |
| 713 | Huntington's Disease (HD) | apoptosis | PRKAR1B | protein kinase cAMP-dependent type I regulatory subunit beta | 0.05 | 0.03 | -0.75 | 0.87 | 0.99 | 5.26 | Detail |
| 714 | Huntington's Disease (HD) | apoptosis | CIDEB | cell death inducing DFFA like effector b | 0.01 | -0.07 | 3.0 | 0.87 | 0.99 | 5.26 | Detail |
| 715 | Huntington's Disease (HD) | apoptosis | EIF5A | eukaryotic translation initiation factor 5A | 0.06 | -0.07 | 0.24 | 0.87 | 0.99 | 5.26 | Detail |
| 716 | Huntington's Disease (HD) | apoptosis | NME5 | NME/NM23 family member 5 | -0.05 | -0.04 | -0.13 | 0.87 | 0.99 | 5.26 | Detail |
| 717 | Huntington's Disease (HD) | apoptosis | WDR35 | WD repeat domain 35 | -0.07 | 0.06 | -0.41 | 0.87 | 0.99 | 5.26 | Detail |
| 718 | Huntington's Disease (HD) | apoptosis | GDNF | glial cell derived neurotrophic factor | 0.03 | 0.05 | 0.73 | 0.88 | 0.99 | 4.93 | Detail |
| 719 | Huntington's Disease (HD) | apoptosis | METTL21C | methyltransferase 21C, AARS1 lysine | 0.08 | 0.05 | -0.8 | 0.88 | 0.99 | 4.93 | Detail |
| 720 | Huntington's Disease (HD) | apoptosis | RRM2B | ribonucleotide reductase regulatory TP53 inducible subunit M2B | -0.07 | -0.08 | 0.16 | 0.88 | 0.99 | 4.93 | Detail |
| 721 | Huntington's Disease (HD) | apoptosis | TNFRSF12A | TNF receptor superfamily member 12A | -0.06 | -0.04 | -0.73 | 0.88 | 0.99 | 4.93 | Detail |
| 722 | Huntington's Disease (HD) | apoptosis | RNH1 | ribonuclease/angiogenin inhibitor 1 | -0.08 | -0.09 | 0.17 | 0.89 | 0.99 | 4.61 | Detail |
| 723 | Huntington's Disease (HD) | apoptosis | DAPK2 | death associated protein kinase 2 | 0.01 | -0.02 | 0.46 | 0.89 | 0.99 | 4.61 | Detail |
| 724 | Huntington's Disease (HD) | apoptosis | EYA1 | EYA transcriptional coactivator and phosphatase 1 | -0.07 | -0.01 | -3.29 | 0.89 | 0.99 | 4.61 | Detail |
| 725 | Huntington's Disease (HD) | apoptosis | GNAI3 | G protein subunit alpha i3 | -0.08 | 0.02 | -2.36 | 0.89 | 0.99 | 4.61 | Detail |
| 726 | Huntington's Disease (HD) | apoptosis | LCK | LCK proto-oncogene, Src family tyrosine kinase | 0.11 | 0.1 | -0.15 | 0.89 | 0.99 | 4.61 | Detail |
| 727 | Huntington's Disease (HD) | apoptosis | LGALS12 | galectin 12 | 0.01 | -0.01 | -0.11 | 0.89 | 0.99 | 4.61 | Detail |
| 728 | Huntington's Disease (HD) | apoptosis | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | -0.0 | -0.02 | 2.67 | 0.89 | 0.99 | 4.61 | Detail |
| 729 | Huntington's Disease (HD) | apoptosis | STK24 | serine/threonine kinase 24 | 0.01 | -0.01 | -0.88 | 0.89 | 0.99 | 4.61 | Detail |
| 730 | Huntington's Disease (HD) | apoptosis | CASP3 | caspase 3 | -0.0 | -0.06 | 4.18 | 0.9 | 0.99 | 4.28 | Detail |
| 731 | Huntington's Disease (HD) | apoptosis | FADD | Fas associated via death domain | 0.04 | 0.03 | -0.46 | 0.9 | 0.99 | 4.28 | Detail |
| 732 | Huntington's Disease (HD) | apoptosis | TRAF2 | TNF receptor associated factor 2 | 0.12 | 0.04 | -1.37 | 0.9 | 0.99 | 4.28 | Detail |
| 733 | Huntington's Disease (HD) | apoptosis | ACVRL1 | activin A receptor like type 1 | 0.07 | -0.02 | -1.76 | 0.9 | 0.99 | 4.28 | Detail |
| 734 | Huntington's Disease (HD) | apoptosis | EIF2AK3 | eukaryotic translation initiation factor 2 alpha kinase 3 | -0.13 | -0.02 | -2.53 | 0.9 | 0.99 | 4.28 | Detail |
| 735 | Huntington's Disease (HD) | apoptosis | IFNB1 | interferon beta 1 | -0.01 | 0.04 | 1.57 | 0.9 | 0.99 | 4.28 | Detail |
| 736 | Huntington's Disease (HD) | apoptosis | RHOT2 | ras homolog family member T2 | 0.14 | 0.07 | -1.05 | 0.9 | 0.99 | 4.28 | Detail |
| 737 | Huntington's Disease (HD) | apoptosis | ZC3HC1 | zinc finger C3HC-type containing 1 | 0.0 | -0.01 | 2.06 | 0.9 | 0.99 | 4.28 | Detail |
| 738 | Huntington's Disease (HD) | apoptosis | PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | -0.04 | -0.06 | 0.61 | 0.91 | 0.99 | 3.95 | Detail |
| 739 | Huntington's Disease (HD) | apoptosis | PXN | paxillin | 0.13 | 0.04 | -1.83 | 0.91 | 0.99 | 3.95 | Detail |
| 740 | Huntington's Disease (HD) | apoptosis | MTOR | mechanistic target of rapamycin kinase | -0.02 | 0.04 | 1.05 | 0.91 | 0.99 | 3.95 | Detail |
| 741 | Huntington's Disease (HD) | apoptosis | CUL5 | cullin 5 | -0.06 | -0.06 | 0.1 | 0.91 | 0.99 | 3.95 | Detail |
| 742 | Huntington's Disease (HD) | apoptosis | AATF | apoptosis antagonizing transcription factor | -0.01 | -0.03 | 1.07 | 0.91 | 0.99 | 3.95 | Detail |
| 743 | Huntington's Disease (HD) | apoptosis | BIRC6 | baculoviral IAP repeat containing 6 | -0.14 | -0.02 | -2.98 | 0.91 | 0.99 | 3.95 | Detail |
| 744 | Huntington's Disease (HD) | apoptosis | FIGNL1 | fidgetin like 1 | -0.06 | -0.09 | 0.53 | 0.91 | 0.99 | 3.95 | Detail |
| 745 | Huntington's Disease (HD) | apoptosis | SMAD1 | SMAD family member 1 | 0.1 | -0.14 | 0.47 | 0.91 | 0.99 | 3.62 | Detail |
| 746 | Huntington's Disease (HD) | apoptosis | BMPR1A | bone morphogenetic protein receptor type 1A | 0.02 | 0.04 | 0.99 | 0.91 | 0.99 | 3.62 | Detail |
| 747 | Huntington's Disease (HD) | apoptosis | PSMB6 | proteasome 20S subunit beta 6 | -0.01 | 0.03 | 2.13 | 0.91 | 0.99 | 3.62 | Detail |
| 748 | Huntington's Disease (HD) | apoptosis | BMPR1B | bone morphogenetic protein receptor type 1B | 0.15 | -0.01 | -4.25 | 0.91 | 0.99 | 3.62 | Detail |
| 749 | Huntington's Disease (HD) | apoptosis | PIK3R5 | phosphoinositide-3-kinase regulatory subunit 5 | -0.04 | 0.02 | -1.18 | 0.91 | 0.99 | 3.62 | Detail |
| 750 | Huntington's Disease (HD) | apoptosis | GGCT | gamma-glutamylcyclotransferase | -0.12 | -0.01 | -3.9 | 0.91 | 0.99 | 3.62 | Detail |
| 751 | Huntington's Disease (HD) | apoptosis | POU4F1 | POU class 4 homeobox 1 | 0.0 | -0.12 | 4.71 | 0.91 | 0.99 | 3.62 | Detail |
| 752 | Huntington's Disease (HD) | apoptosis | RPL11 | ribosomal protein L11 | 0.11 | 0.08 | -0.5 | 0.91 | 0.99 | 3.62 | Detail |
| 753 | Huntington's Disease (HD) | apoptosis | KRT8 | keratin 8 | 0.13 | 0.07 | -0.88 | 0.91 | 0.99 | 3.62 | Detail |
| 754 | Huntington's Disease (HD) | apoptosis | BMP2 | bone morphogenetic protein 2 | -0.06 | -0.02 | -1.83 | 0.92 | 0.99 | 3.29 | Detail |
| 755 | Huntington's Disease (HD) | apoptosis | DCN | decorin | 0.04 | 0.03 | -0.37 | 0.92 | 0.99 | 3.29 | Detail |
| 756 | Huntington's Disease (HD) | apoptosis | TRADD | TNFRSF1A associated via death domain | 0.06 | 0.02 | -1.68 | 0.92 | 0.99 | 3.29 | Detail |
| 757 | Huntington's Disease (HD) | apoptosis | CLCN7 | chloride voltage-gated channel 7 | 0.02 | -0.01 | -1.53 | 0.92 | 0.99 | 3.29 | Detail |
| 758 | Huntington's Disease (HD) | apoptosis | PSMD13 | proteasome 26S subunit, non-ATPase 13 | 0.06 | -0.05 | -0.09 | 0.92 | 0.99 | 3.29 | Detail |
| 759 | Huntington's Disease (HD) | apoptosis | NTRK2 | neurotrophic receptor tyrosine kinase 2 | -0.0 | -0.05 | 3.83 | 0.92 | 0.99 | 3.29 | Detail |
| 760 | Huntington's Disease (HD) | apoptosis | ZNF304 | zinc finger protein 304 | -0.03 | -0.06 | 0.93 | 0.92 | 0.99 | 3.29 | Detail |
| 761 | Huntington's Disease (HD) | apoptosis | MUC1 | mucin 1, cell surface associated | 0.1 | 0.11 | 0.02 | 0.92 | 0.99 | 3.29 | Detail |
| 762 | Huntington's Disease (HD) | apoptosis | RHOT1 | ras homolog family member T1 | 0.0 | -0.02 | 4.48 | 0.92 | 0.99 | 3.29 | Detail |
| 763 | Huntington's Disease (HD) | apoptosis | SIVA1 | SIVA1 apoptosis inducing factor | 0.04 | -0.0 | -3.05 | 0.92 | 0.99 | 3.29 | Detail |
| 764 | Huntington's Disease (HD) | apoptosis | TM2D1 | TM2 domain containing 1 | -0.08 | -0.1 | 0.38 | 0.92 | 0.99 | 3.29 | Detail |
| 765 | Huntington's Disease (HD) | apoptosis | VDAC2 | voltage dependent anion channel 2 | -0.01 | 0.03 | 1.04 | 0.92 | 0.99 | 3.29 | Detail |
| 766 | Huntington's Disease (HD) | apoptosis | MYD88 | MYD88 innate immune signal transduction adaptor | 0.05 | -0.05 | 0.01 | 0.93 | 0.99 | 2.96 | Detail |
| 767 | Huntington's Disease (HD) | apoptosis | PLA2G1B | phospholipase A2 group IB | 0.11 | 0.1 | -0.18 | 0.93 | 0.99 | 2.96 | Detail |
| 768 | Huntington's Disease (HD) | apoptosis | TNFRSF1A | TNF receptor superfamily member 1A | 0.09 | 0.03 | -1.48 | 0.93 | 0.99 | 2.96 | Detail |
| 769 | Huntington's Disease (HD) | apoptosis | THBS2 | thrombospondin 2 | -0.03 | -0.07 | 1.26 | 0.93 | 0.99 | 2.96 | Detail |
| 770 | Huntington's Disease (HD) | apoptosis | NOG | noggin | 0.01 | 0.06 | 2.34 | 0.93 | 0.99 | 2.96 | Detail |
| 771 | Huntington's Disease (HD) | apoptosis | INHBE | inhibin subunit beta E | -0.0 | 0.06 | 4.2 | 0.93 | 0.99 | 2.96 | Detail |
| 772 | Huntington's Disease (HD) | apoptosis | MYBBP1A | MYB binding protein 1a | 0.12 | 0.07 | -0.76 | 0.93 | 0.99 | 2.96 | Detail |
| 773 | Huntington's Disease (HD) | apoptosis | BCLAF1 | BCL2 associated transcription factor 1 | -0.14 | -0.03 | -2.2 | 0.93 | 0.99 | 2.96 | Detail |
| 774 | Huntington's Disease (HD) | apoptosis | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | -0.09 | -0.02 | -1.93 | 0.93 | 0.99 | 2.96 | Detail |
| 775 | Huntington's Disease (HD) | apoptosis | EPHA2 | EPH receptor A2 | 0.08 | 0.15 | 0.93 | 0.93 | 0.99 | 2.96 | Detail |
| 776 | Huntington's Disease (HD) | apoptosis | RAD9A | RAD9 checkpoint clamp component A | 0.06 | 0.04 | -0.61 | 0.93 | 0.99 | 2.96 | Detail |
| 777 | Huntington's Disease (HD) | apoptosis | RB1CC1 | RB1 inducible coiled-coil 1 | -0.06 | -0.04 | -0.64 | 0.93 | 0.99 | 2.96 | Detail |
| 778 | Huntington's Disease (HD) | apoptosis | UNC5B | unc-5 netrin receptor B | 0.01 | -0.06 | 3.39 | 0.93 | 0.99 | 2.96 | Detail |
| 779 | Huntington's Disease (HD) | apoptosis | CASP7 | caspase 7 | -0.08 | -0.01 | -3.51 | 0.94 | 0.99 | 2.63 | Detail |
| 780 | Huntington's Disease (HD) | apoptosis | PXDN | peroxidasin | 0.24 | 0.03 | -2.88 | 0.94 | 0.99 | 2.63 | Detail |
| 781 | Huntington's Disease (HD) | apoptosis | ATF2 | activating transcription factor 2 | -0.06 | -0.08 | 0.28 | 0.94 | 0.99 | 2.63 | Detail |
| 782 | Huntington's Disease (HD) | apoptosis | CD5 | CD5 molecule | 0.09 | 0.09 | 0.06 | 0.94 | 0.99 | 2.63 | Detail |
| 783 | Huntington's Disease (HD) | apoptosis | CSNK2A2 | casein kinase 2 alpha 2 | 0.08 | 0.07 | -0.24 | 0.94 | 0.99 | 2.63 | Detail |
| 784 | Huntington's Disease (HD) | apoptosis | HIF1A | hypoxia inducible factor 1 subunit alpha | -0.01 | -0.02 | 1.66 | 0.94 | 0.99 | 2.63 | Detail |
| 785 | Huntington's Disease (HD) | apoptosis | HTRA2 | HtrA serine peptidase 2 | 0.02 | -0.04 | 0.51 | 0.94 | 0.99 | 2.63 | Detail |
| 786 | Huntington's Disease (HD) | apoptosis | MAGED1 | MAGE family member D1 | 0.07 | 0.08 | 0.24 | 0.94 | 0.99 | 2.63 | Detail |
| 787 | Huntington's Disease (HD) | apoptosis | PDX1 | pancreatic and duodenal homeobox 1 | 0.14 | 0.11 | -0.25 | 0.94 | 0.99 | 2.63 | Detail |
| 788 | Huntington's Disease (HD) | apoptosis | PEA15 | proliferation and apoptosis adaptor protein 15 | -0.08 | -0.02 | -2.23 | 0.94 | 0.99 | 2.63 | Detail |
| 789 | Huntington's Disease (HD) | apoptosis | TNFAIP3 | TNF alpha induced protein 3 | -0.14 | 0.07 | -1.01 | 0.94 | 0.99 | 2.63 | Detail |
| 790 | Huntington's Disease (HD) | apoptosis | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | -0.05 | -0.04 | -0.41 | 0.94 | 0.99 | 2.63 | Detail |
| 791 | Huntington's Disease (HD) | apoptosis | SMAD9 | SMAD family member 9 | 0.01 | -0.0 | -2.11 | 0.95 | 0.99 | 2.3 | Detail |
| 792 | Huntington's Disease (HD) | apoptosis | NLE1 | notchless homolog 1 | 0.09 | 0.03 | -1.37 | 0.95 | 0.99 | 2.3 | Detail |
| 793 | Huntington's Disease (HD) | apoptosis | TNFRSF10D | TNF receptor superfamily member 10d | 0.09 | 0.09 | 0.11 | 0.95 | 0.99 | 2.3 | Detail |
| 794 | Huntington's Disease (HD) | apoptosis | CHP2 | calcineurin like EF-hand protein 2 | 0.04 | 0.06 | 0.59 | 0.95 | 0.99 | 2.3 | Detail |
| 795 | Huntington's Disease (HD) | apoptosis | FASTK | Fas activated serine/threonine kinase | 0.11 | 0.05 | -1.16 | 0.95 | 0.99 | 2.3 | Detail |
| 796 | Huntington's Disease (HD) | apoptosis | NMT1 | N-myristoyltransferase 1 | -0.06 | -0.0 | -5.01 | 0.95 | 0.99 | 2.3 | Detail |
| 797 | Huntington's Disease (HD) | apoptosis | CSF2 | colony stimulating factor 2 | 0.03 | 0.02 | -1.01 | 0.96 | 1.0 | 1.97 | Detail |
| 798 | Huntington's Disease (HD) | apoptosis | FHIT | fragile histidine triad diadenosine triphosphatase | 0.02 | 0.08 | 1.77 | 0.96 | 1.0 | 1.97 | Detail |
| 799 | Huntington's Disease (HD) | apoptosis | PML | PML nuclear body scaffold | 0.04 | 0.02 | -1.58 | 0.96 | 1.0 | 1.97 | Detail |
| 800 | Huntington's Disease (HD) | apoptosis | SHISA5 | shisa family member 5 | 0.01 | 0.01 | 0.97 | 0.96 | 1.0 | 1.97 | Detail |
| 801 | Huntington's Disease (HD) | apoptosis | VEGFA | vascular endothelial growth factor A | -0.02 | -0.1 | 2.07 | 0.96 | 1.0 | 1.64 | Detail |
| 802 | Huntington's Disease (HD) | apoptosis | ACVR2B | activin A receptor type 2B | 0.03 | 0.06 | 0.92 | 0.96 | 1.0 | 1.64 | Detail |
| 803 | Huntington's Disease (HD) | apoptosis | KDM1A | lysine demethylase 1A | 0.05 | 0.02 | -1.48 | 0.96 | 1.0 | 1.64 | Detail |
| 804 | Huntington's Disease (HD) | apoptosis | SST | somatostatin | -0.07 | 0.05 | -0.36 | 0.96 | 1.0 | 1.64 | Detail |
| 805 | Huntington's Disease (HD) | apoptosis | LY96 | lymphocyte antigen 96 | 0.06 | 0.07 | 0.3 | 0.96 | 1.0 | 1.64 | Detail |
| 806 | Huntington's Disease (HD) | apoptosis | IFNG | interferon gamma | -0.0 | 0.08 | 4.47 | 0.97 | 1.0 | 1.32 | Detail |
| 807 | Huntington's Disease (HD) | apoptosis | THBS1 | thrombospondin 1 | -0.05 | -0.03 | -1.04 | 0.97 | 1.0 | 1.32 | Detail |
| 808 | Huntington's Disease (HD) | apoptosis | CHEK2 | checkpoint kinase 2 | -0.09 | -0.1 | 0.27 | 0.97 | 1.0 | 1.32 | Detail |
| 809 | Huntington's Disease (HD) | apoptosis | ING2 | inhibitor of growth family member 2 | 0.07 | 0.01 | -3.25 | 0.97 | 1.0 | 1.32 | Detail |
| 810 | Huntington's Disease (HD) | apoptosis | TNFRSF1B | TNF receptor superfamily member 1B | -0.07 | -0.02 | -2.05 | 0.97 | 1.0 | 1.32 | Detail |
| 811 | Huntington's Disease (HD) | apoptosis | COMP | cartilage oligomeric matrix protein | 0.11 | 0.0 | -5.08 | 0.98 | 1.0 | 0.99 | Detail |
| 812 | Huntington's Disease (HD) | apoptosis | ATAD5 | ATPase family AAA domain containing 5 | -0.12 | -0.12 | 0.04 | 0.98 | 1.0 | 0.99 | Detail |
| 813 | Huntington's Disease (HD) | apoptosis | FXN | frataxin | -0.05 | -0.03 | -0.5 | 0.98 | 1.0 | 0.99 | Detail |
| 814 | Huntington's Disease (HD) | apoptosis | SLC25A31 | solute carrier family 25 member 31 | -0.03 | 0.05 | 0.91 | 0.98 | 1.0 | 0.99 | Detail |
| 815 | Huntington's Disease (HD) | apoptosis | NFKB1 | nuclear factor kappa B subunit 1 | 0.04 | 0.11 | 1.51 | 0.99 | 1.0 | 0.66 | Detail |
| 816 | Huntington's Disease (HD) | apoptosis | NFAT5 | nuclear factor of activated T cells 5 | 0.0 | 0.06 | 3.62 | 0.99 | 1.0 | 0.66 | Detail |
| 817 | Huntington's Disease (HD) | apoptosis | ERN1 | endoplasmic reticulum to nucleus signaling 1 | -0.11 | -0.03 | -1.8 | 0.99 | 1.0 | 0.66 | Detail |
| 818 | Huntington's Disease (HD) | apoptosis | GSKIP | GSK3B interacting protein | 0.03 | 0.04 | 0.6 | 0.99 | 1.0 | 0.66 | Detail |
| 819 | Huntington's Disease (HD) | apoptosis | IL2 | interleukin 2 | -0.06 | -0.04 | -0.71 | 0.99 | 1.0 | 0.66 | Detail |
| 820 | Huntington's Disease (HD) | apoptosis | RNF183 | ring finger protein 183 | 0.0 | 0.13 | 7.11 | 0.99 | 1.0 | 0.66 | Detail |
| 821 | Huntington's Disease (HD) | apoptosis | SNAI1 | snail family transcriptional repressor 1 | 0.02 | -0.02 | -0.15 | 0.99 | 1.0 | 0.66 | Detail |
| 822 | Huntington's Disease (HD) | apoptosis | BAX | BCL2 associated X, apoptosis regulator | 0.06 | 0.03 | -1.09 | 1.0 | 1.0 | 0.33 | Detail |
| 823 | Huntington's Disease (HD) | apoptosis | SATB1 | SATB homeobox 1 | 0.03 | 0.01 | -1.63 | 1.0 | 1.0 | 0.33 | Detail |
| 824 | Huntington's Disease (HD) | apoptosis | SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | -0.02 | -0.08 | 2.36 | 1.0 | 1.0 | 0.33 | Detail |
| 825 | Huntington's Disease (HD) | apoptosis | LMNB1 | lamin B1 | -0.03 | -0.0 | -3.36 | 1.0 | 1.0 | 0.33 | Detail |
| 826 | Huntington's Disease (HD) | apoptosis | HTT | huntingtin | -0.02 | 0.05 | 1.54 | 1.0 | 1.0 | 0.33 | Detail |
| 827 | Huntington's Disease (HD) | apoptosis | LRRK2 | leucine rich repeat kinase 2 | -0.1 | -0.02 | -2.16 | 1.0 | 1.0 | 0.33 | Detail |
| 828 | Huntington's Disease (HD) | apoptosis | MELK | maternal embryonic leucine zipper kinase | 0.1 | 0.03 | -1.93 | 1.0 | 1.0 | 0.33 | Detail |
| 829 | Huntington's Disease (HD) | apoptosis | NFE2L2 | NFE2 like bZIP transcription factor 2 | -0.05 | -0.07 | 0.55 | 1.0 | 1.0 | 0.33 | Detail |
| 830 | Huntington's Disease (HD) | apoptosis | PTPN1 | protein tyrosine phosphatase non-receptor type 1 | 0.03 | 0.04 | 0.42 | 1.0 | 1.0 | 0.33 | Detail |
| 831 | Huntington's Disease (HD) | apoptosis | RPS3 | ribosomal protein S3 | 0.07 | 0.09 | 0.35 | 1.0 | 1.0 | 0.33 | Detail |
| 832 | Huntington's Disease (HD) | apoptosis | RRP8 | ribosomal RNA processing 8 | 0.06 | 0.01 | -3.22 | 1.0 | 1.0 | 0.33 | Detail |
| 833 | Huntington's Disease (HD) | apoptosis | AMH | anti-Mullerian hormone | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 834 | Huntington's Disease (HD) | apoptosis | NRAS | NRAS proto-oncogene, GTPase | -0.07 | -0.08 | 0.1 | 1.0 | 1.0 | 0.0 | Detail |
| 835 | Huntington's Disease (HD) | apoptosis | SEM1 | SEM1 26S proteasome subunit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 836 | Huntington's Disease (HD) | apoptosis | JMJD7-PLA2G4B | JMJD7-PLA2G4B readthrough | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 837 | Huntington's Disease (HD) | apoptosis | PLA2G4B | phospholipase A2 group IVB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 838 | Huntington's Disease (HD) | apoptosis | PSME2 | proteasome activator subunit 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 839 | Huntington's Disease (HD) | apoptosis | GDF7 | growth differentiation factor 7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 840 | Huntington's Disease (HD) | apoptosis | PLA2G10 | phospholipase A2 group X | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 841 | Huntington's Disease (HD) | apoptosis | NAA80 | N-alpha-acetyltransferase 80, NatH catalytic subunit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 842 | Huntington's Disease (HD) | apoptosis | PSMA6 | proteasome 20S subunit alpha 6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 843 | Huntington's Disease (HD) | apoptosis | LEFTY2 | left-right determination factor 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 844 | Huntington's Disease (HD) | apoptosis | GDF6 | growth differentiation factor 6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 845 | Huntington's Disease (HD) | apoptosis | PLA2G2C | phospholipase A2 group IIC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 846 | Huntington's Disease (HD) | apoptosis | PLA2G4E | phospholipase A2 group IVE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 847 | Huntington's Disease (HD) | apoptosis | PSMA6P4 | proteasome subunit alpha 6 pseudogene 4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 848 | Huntington's Disease (HD) | apoptosis | PSMB11 | proteasome subunit beta 11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 849 | Huntington's Disease (HD) | apoptosis | PSMC1P4 | proteasome 26S subunit, ATPase 1 pseudogene 4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 850 | Huntington's Disease (HD) | apoptosis | RNASEH1P1 | ribonuclease H1 pseudogene 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 851 | Huntington's Disease (HD) | apoptosis | TLE5 | TLE family member 5, transcriptional modulator | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 852 | Huntington's Disease (HD) | apoptosis | ADORA2A | adenosine A2a receptor | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 853 | Huntington's Disease (HD) | apoptosis | ASAH2 | N-acylsphingosine amidohydrolase 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 854 | Huntington's Disease (HD) | apoptosis | ATP5IF1 | ATP synthase inhibitory factor subunit 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 855 | Huntington's Disease (HD) | apoptosis | BBC3 | BCL2 binding component 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 856 | Huntington's Disease (HD) | apoptosis | BCL3 | BCL3 transcription coactivator | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 857 | Huntington's Disease (HD) | apoptosis | BEX3 | brain expressed X-linked 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 858 | Huntington's Disease (HD) | apoptosis | BLOC1S2 | biogenesis of lysosomal organelles complex 1 subunit 2 | 0.01 | -0.0 | -1.56 | 1.0 | 1.0 | 0.0 | Detail |
| 859 | Huntington's Disease (HD) | apoptosis | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 860 | Huntington's Disease (HD) | apoptosis | C8orf44-SGK3 | C8orf44-SGK3 readthrough | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 861 | Huntington's Disease (HD) | apoptosis | COA8 | cytochrome c oxidase assembly factor 8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 862 | Huntington's Disease (HD) | apoptosis | DDX47 | DEAD-box helicase 47 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 863 | Huntington's Disease (HD) | apoptosis | DELE1 | DAP3 binding cell death enhancer 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 864 | Huntington's Disease (HD) | apoptosis | ERO1A | endoplasmic reticulum oxidoreductase 1 alpha | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 865 | Huntington's Disease (HD) | apoptosis | FBH1 | F-box DNA helicase 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 866 | Huntington's Disease (HD) | apoptosis | GFRAL | GDNF family receptor alpha like | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 867 | Huntington's Disease (HD) | apoptosis | GSDME | gasdermin E | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 868 | Huntington's Disease (HD) | apoptosis | HSPA1A | heat shock protein family A (Hsp70) member 1A | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 869 | Huntington's Disease (HD) | apoptosis | HSPA1B | heat shock protein family A (Hsp70) member 1B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 870 | Huntington's Disease (HD) | apoptosis | ITGAV | integrin subunit alpha V | -0.05 | 0.02 | -1.52 | 1.0 | 1.0 | 0.0 | Detail |
| 871 | Huntington's Disease (HD) | apoptosis | MAGEA3 | MAGE family member A3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 872 | Huntington's Disease (HD) | apoptosis | MARCHF7 | membrane associated ring-CH-type finger 7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 873 | Huntington's Disease (HD) | apoptosis | MIR132 | microRNA 132 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 874 | Huntington's Disease (HD) | apoptosis | MIR15A | microRNA 15a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 875 | Huntington's Disease (HD) | apoptosis | MIR16-1 | microRNA 16-1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 876 | Huntington's Disease (HD) | apoptosis | MIR17 | microRNA 17 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 877 | Huntington's Disease (HD) | apoptosis | MIR186 | microRNA 186 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 878 | Huntington's Disease (HD) | apoptosis | MIR198 | microRNA 198 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 879 | Huntington's Disease (HD) | apoptosis | MIR21 | microRNA 21 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 880 | Huntington's Disease (HD) | apoptosis | MIR210 | microRNA 210 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 881 | Huntington's Disease (HD) | apoptosis | MIR221 | microRNA 221 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 882 | Huntington's Disease (HD) | apoptosis | MIR222 | microRNA 222 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 883 | Huntington's Disease (HD) | apoptosis | MIR26B | microRNA 26b | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 884 | Huntington's Disease (HD) | apoptosis | MIR27B | microRNA 27b | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 885 | Huntington's Disease (HD) | apoptosis | MIR449A | microRNA 449a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 886 | Huntington's Disease (HD) | apoptosis | NR4A2 | nuclear receptor subfamily 4 group A member 2 | -0.05 | 0.05 | -0.04 | 1.0 | 1.0 | 0.0 | Detail |
| 887 | Huntington's Disease (HD) | apoptosis | PAK5 | p21 (RAC1) activated kinase 5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 888 | Huntington's Disease (HD) | apoptosis | PLSCR3 | phospholipid scramblase 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 889 | Huntington's Disease (HD) | apoptosis | PRKN | parkin RBR E3 ubiquitin protein ligase | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 890 | Huntington's Disease (HD) | apoptosis | PRODH | proline dehydrogenase 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 891 | Huntington's Disease (HD) | apoptosis | QARS1 | glutaminyl-tRNA synthetase 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 892 | Huntington's Disease (HD) | apoptosis | RACK1 | receptor for activated C kinase 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 893 | Huntington's Disease (HD) | apoptosis | RPL26 | ribosomal protein L26 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 894 | Huntington's Disease (HD) | apoptosis | RTL10 | retrotransposon Gag like 10 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 895 | Huntington's Disease (HD) | apoptosis | SCRT2 | scratch family transcriptional repressor 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 896 | Huntington's Disease (HD) | apoptosis | SELENOK | selenoprotein K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 897 | Huntington's Disease (HD) | apoptosis | SELENOS | selenoprotein S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 898 | Huntington's Disease (HD) | apoptosis | SEPTIN4 | septin 4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 899 | Huntington's Disease (HD) | apoptosis | SGK3 | serum/glucocorticoid regulated kinase family member 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 900 | Huntington's Disease (HD) | apoptosis | SYVN1 | synoviolin 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 901 | Huntington's Disease (HD) | apoptosis | TAF9 | TATA-box binding protein associated factor 9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 902 | Huntington's Disease (HD) | apoptosis | TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 903 | Huntington's Disease (HD) | apoptosis | TNFSF12 | TNF superfamily member 12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 904 | Huntington's Disease (HD) | apoptosis | TPT1 | tumor protein, translationally-controlled 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 905 | Huntington's Disease (HD) | apoptosis | TRIM39 | tripartite motif containing 39 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 906 | Huntington's Disease (HD) | apoptosis | INCA1 | inhibitor of CDK, cyclin A1 interacting protein 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
| 907 | Huntington's Disease (HD) | apoptosis | TICAM2 | TIR domain containing adaptor molecule 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Detail |
Ensemble learning visualization:
Ensemble learning for Huntington's Disease (HD) based on specific apoptosis gene regulaors.
_apoptosis.png)
_apoptosis.png)